7Baggers

Gentherm Incorporated
(NASDAQ:THRM) 

THRM stock logo

Gentherm Incorporated designs, develops, manufactures, and markets thermal management technologies. The company operates through two segments, Automotive and Medical. The Automotive segment offers climate comfort system solutions, which include seat heaters, blowers, and thermoelectric devices for v...

Founded: 1991
Full Time Employees: 11,000
Sector: Consumer Cyclical
Industry: Auto Parts

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 
                                                                                                 
      product revenues
    382,788,000 386,870,000 375,090,000 353,854,000 352,914,000 371,512,000 375,683,000 356,015,000 366,933,000 366,195,000 372,323,000 363,625,000 343,322,000 332,962,000 260,715,000 267,657,000 248,226,000 243,384,000 266,005,000 288,535,000 288,884,000 259,540,000 136,061,000 228,613,000 230,381,000 240,056,000 243,326,000 257,921,000 253,652,000 258,939,000 263,779,000 261,889,000 257,185,000 235,853,000 243,378,000 249,267,000 236,541,000 232,625,000 232,720,000 215,714,000 212,277,000 223,818,000 213,441,000 206,909,000 205,168,000 206,012,000 206,182,000 193,938,000 182,290,000 171,182,000 160,520,000 148,090,000 148,242,000 141,058,000 136,153,000 129,526,000 131,016,000 125,639,000 77,137,000 35,796,000 28,917,000 30,486,000 28,812,000 24,188,000 21,598,000 18,442,000 10,715,000 10,170,000 12,826,000 16,631,000 16,796,000 17,360,000 16,390,000 15,909,000 15,058,000 16,273,000 15,030,000 12,729,000 12,409,000 10,441,000 9,962,000 8,256,000 8,562,000 8,957,000  8,942,000 9,210,000 5,644,000 5,246,000 6,423,000 4,491,000 2,832,000 1,525,000 
      cost of sales
    291,987,000 291,722,000 285,328,000 267,389,000 266,810,000 276,639,000 278,982,000 267,262,000 270,637,000 279,985,000 284,335,000 282,495,000 273,514,000 252,610,000 201,338,000 203,544,000 180,864,000 173,997,000 186,792,000 200,866,000 196,187,000 176,935,000 109,326,000 162,546,000 164,759,000 165,364,000 170,612,000 182,614,000 185,195,000 185,800,000 189,308,000 183,322,000 179,866,000 165,624,000 164,973,000 164,107,000 157,935,000 155,931,000 161,225,000 147,472,000 143,099,000 148,892,000 147,736,000 140,339,000 142,853,000 144,427,000 145,425,000 136,913,000 132,648,000 125,265,000 120,368,000 109,039,000 109,777,000 104,258,000 101,940,000 97,077,000 97,170,000 94,795,000 57,918,000 25,340,000 20,330,000 21,681,000 20,108,000 17,545,000 15,333,000 13,897,000 8,184,000 7,752,000 9,970,000 11,798,000 11,517,000 11,801,000 10,604,000 10,736,000 9,903,000 11,059,000 9,880,000 8,570,000 8,526,000 7,133,000 6,864,000 5,611,000 6,104,000 6,493,000  7,171,000 7,414,000 4,246,000 4,171,000 5,109,000 3,444,000 2,106,000 1,324,000 
      gross margin
    90,801,000 95,148,000 89,762,000 86,465,000 86,104,000 94,873,000 96,701,000 88,753,000 96,296,000 86,210,000 87,988,000 81,130,000 69,808,000 80,352,000 59,377,000 64,113,000 67,362,000 69,387,000 79,213,000 87,669,000 92,697,000 82,605,000 26,735,000 66,067,000 65,622,000 74,692,000 72,714,000 75,307,000 68,457,000 73,139,000 74,471,000 78,567,000 77,319,000 70,229,000 78,405,000 85,160,000 78,606,000 76,694,000 71,495,000 68,242,000 69,178,000 74,926,000 65,705,000 66,570,000 62,315,000 61,585,000 60,757,000 57,025,000 49,642,000 45,917,000 40,152,000 39,051,000 38,465,000 36,800,000 34,213,000 32,449,000 33,846,000 30,844,000 19,219,000 10,456,000 8,587,000 8,805,000 8,704,000 6,643,000 6,265,000 4,545,000 2,531,000 2,418,000 2,856,000 4,833,000 5,279,000 5,559,000 5,786,000 5,173,000 5,155,000 5,214,000 5,150,000 4,159,000 3,883,000 3,308,000 3,098,000 2,645,000 2,458,000 2,464,000  1,771,000 1,796,000 1,398,000 1,075,000 1,314,000 1,047,000 726,000 201,000 
      yoy
    5.46% 0.29% -7.18% -2.58% -10.58% 10.05% 9.90% 9.40% 37.94% 7.29% 48.19% 26.54% 3.63% 15.80% -25.04% -26.87% -27.33% -16.00% 196.29% 32.70% 41.26% 10.59% -63.23% -12.27% -4.14% 2.12% -2.36% -4.15% -11.46% 4.14% -5.02% -7.74% -1.64% -8.43% 9.67% 24.79% 13.63% 2.36% 8.81% 2.51% 11.01% 21.66% 8.14% 16.74% 25.53% 34.12% 51.32% 46.03% 29.06% 24.77% 17.36% 20.35% 13.65% 19.31% 78.02% 210.34% 294.15% 250.30% 120.81% 57.40% 37.06% 93.73% 243.90% 174.73% 119.36% -5.96% -52.06% -56.50% -50.64% -6.57% 2.41% 6.62% 12.35% 24.38% 32.76% 57.62% 66.24% 57.24% 57.97% 34.25%  49.35% 36.86% 76.25%  34.78% 71.54% 92.56% 434.83%     
      qoq
    -4.57% 6.00% 3.81% 0.42% -9.24% -1.89% 8.96% -7.83% 11.70% -2.02% 8.45% 16.22% -13.12% 35.33% -7.39% -4.82% -2.92% -12.40% -9.65% -5.42% 12.22% 208.98% -59.53% 0.68% -12.14% 2.72% -3.44% 10.01% -6.40% -1.79% -5.21% 1.61% 10.10% -10.43% -7.93% 8.34% 2.49% 7.27% 4.77% -1.35% -7.67% 14.03% -1.30% 6.83% 1.19% 1.36% 6.54% 14.87% 8.11% 14.36% 2.82% 1.52% 4.52% 7.56% 5.44% -4.13% 9.73% 60.49% 83.81% 21.77% -2.48% 1.16% 31.03% 6.03% 37.84% 79.57% 4.67% -15.34% -40.91% -8.45% -5.04% -3.92% 11.85% 0.35% -1.13% 1.24% 23.83% 7.11% 17.38% 6.78% 17.13% 7.61% -0.24%   -1.39% 28.47% 30.05% -18.19% 25.50% 44.21% 261.19%  
      operating expenses:
                                                                                                 
      net research and development expenses
    23,556,000 24,429,000 22,558,000 24,216,000 21,078,000 23,013,000 21,861,000 22,745,000 21,367,000 23,150,000 24,696,000 25,145,000 23,297,000 22,666,000 19,325,000 20,434,000 18,794,000 20,590,000 18,227,000 17,603,000 16,869,000 18,070,000 15,341,000 17,760,000 15,486,000 18,838,000 19,255,000 18,897,000 16,518,000 19,056,000 21,022,000 23,304,000 21,845,000 19,721,000 21,407,000 19,505,000 18,371,000 19,745,000 19,111,000 15,696,000 15,145,000 14,934,000 14,977,000 14,548,000 14,653,000 15,278,000 14,550,000 13,045,000 12,911,000 12,718,000 12,403,000 11,841,000 11,233,000 10,046,000 9,912,000 9,759,000 10,100,000 11,285,000 4,586,000 2,469,000 2,688,000 2,299,000 2,862,000 1,804,000 1,352,000 1,322,000 1,574,000 1,746,000 1,722,000 1,974,000 1,497,000 1,590,000 1,227,000 1,371,000 1,340,000 1,143,000 845,000 996,000 890,000 636,000              
      selling, general and administrative expenses
    47,605,000 42,875,000 41,087,000 38,478,000 38,116,000 36,861,000 39,410,000 40,721,000 41,899,000 38,220,000 38,418,000 37,042,000 36,584,000 34,859,000 31,943,000 29,308,000 26,461,000 27,344,000 27,223,000 28,526,000 31,570,000 25,745,000 21,889,000 25,840,000 26,997,000 26,861,000 31,829,000 32,613,000 29,232,000 32,552,000 31,641,000 34,592,000 33,610,000 34,331,000 31,775,000 30,806,000 33,719,000 29,512,000 29,397,000                                                       
      restructuring expenses
    1,868,000 3,986,000 2,108,000 4,514,000 768,000 2,662,000 2,442,000 7,238,000 1,327,000 1,099,000 1,044,000 1,269,000 76,000 6,000 374,000 181,000 226,000 749,000 2,091,000 791,000 2,351,000 284,000 -598,000 3,766,000 1,110,000 8,664,000 1,231,000 1,914,000 1,874,000 5,818,000 6,215,000                                                               
      loss on sale of land and building
       2,196,000                                                                                          
      total operating expenses
    73,029,000 71,290,000 65,753,000 69,404,000 62,463,000 62,536,000 63,713,000 70,704,000 64,593,000 62,469,000 83,667,000 63,456,000 66,248,000 57,531,000 51,642,000 49,923,000 45,481,000 48,683,000 47,541,000 46,920,000 50,790,000 44,099,000 36,632,000 47,366,000 43,593,000 54,363,000 52,657,000 53,462,000 43,550,000 57,426,000 58,878,000 57,896,000 39,386,250 54,052,000 53,182,000 50,311,000 34,194,500 49,279,000 49,142,000 38,357,000 29,001,250 37,477,000 39,035,000 39,493,000 26,579,000 37,585,000 36,522,000 32,209,000 23,089,000 31,363,000 31,733,000 29,260,000 18,922,250 26,606,000 25,351,000 23,732,000 12,453,000 25,030,000 15,195,000 9,587,000 3,603,500 4,797,000 5,353,000 4,264,000 2,740,250 3,326,000 3,740,000 3,895,000 2,806,250 3,979,000 3,529,000 3,717,000 2,537,250 3,490,000 3,363,000 3,296,000                  
      operating income
    17,772,000 23,858,000 24,009,000 17,061,000 23,641,000 32,337,000 32,988,000 18,049,000 31,703,000 23,741,000 4,321,000 17,674,000 3,560,000 22,821,000 7,735,000 14,190,000 21,881,000 20,704,000 31,672,000 40,749,000 41,907,000 38,506,000 -9,897,000 18,701,000 22,029,000 20,329,000 20,057,000 21,845,000 20,833,000 15,713,000 15,593,000 20,671,000 21,075,000 16,177,000 25,223,000 34,849,000 26,466,000 27,415,000 22,353,000 29,885,000 30,123,000 37,449,000 26,670,000 27,077,000 25,383,000 24,000,000 24,235,000 24,816,000 16,816,000 14,554,000 8,419,000 9,791,000 8,285,000 10,194,000 8,862,000 8,717,000 7,792,000 5,814,000 4,024,000 869,000 2,393,000 4,008,000 3,351,000 2,379,000 2,375,000 1,219,000 -1,209,000 -1,477,000 108,000 854,000 1,750,000 1,842,000 2,312,000 1,683,000 1,792,000 1,918,000 1,996,000 1,294,000 1,145,000 1,078,000 1,117,000 748,000 338,000 367,000  225,000 -193,000 -632,000 -954,000 -1,184,000 -1,418,000 -1,659,000 -1,914,000 
      yoy
    -24.83% -26.22% -27.22% -5.47% -25.43% 36.21% 663.43% 2.12% 790.53% 4.03% -44.14% 24.55% -83.73% 10.23% -75.58% -65.18% -47.79% -46.23% -420.02% 117.90% 90.24% 89.41% -149.34% -14.39% 5.74% 29.38% 28.63% 5.68% -1.15% -2.87% -38.18% -40.68% -20.37% -40.99% 12.84% 16.61% -12.14% -26.79% -16.19% 10.37% 18.67% 56.04% 10.05% 9.11% 50.95% 64.90% 187.86% 153.46% 102.97% 42.77% -5.00% 12.32% 6.33% 75.34% 120.23% 903.11% 225.62% 45.06% 20.08% -63.47% 0.76% 228.79% -377.17% -261.07% 2099.07% 42.74% -169.09% -180.18% -95.33% -49.26% -2.34% -3.96% 15.83% 30.06% 56.51% 77.92% 78.69% 72.99% 238.76% 193.73%  232.44% -275.13% -158.07%  -119.00% -86.39% -61.90% -50.16%     
      qoq
    -25.51% -0.63% 40.72% -27.83% -26.89% -1.97% 82.77% -43.07% 33.54% 449.43% -75.55% 396.46% -84.40% 195.04% -45.49% -35.15% 5.68% -34.63% -22.28% -2.76% 8.83% -489.07% -152.92% -15.11% 8.36% 1.36% -8.18% 4.86% 32.58% 0.77% -24.57% -1.92% 30.28% -35.86% -27.62% 31.67% -3.46% 22.65% -25.20% -0.79% -19.56% 40.42% -1.50% 6.67% 5.76% -0.97% -2.34% 47.57% 15.54% 72.87% -14.01% 18.18% -18.73% 15.03% 1.66% 11.87% 34.02% 44.48% 363.06% -63.69% -40.29% 19.61% 40.86% 0.17% 94.83% -200.83% -18.14% -1467.59% -87.35% -51.20% -4.99% -20.33% 37.37% -6.08% -6.57% -3.91% 54.25% 13.01% 6.22% -3.49% 49.33% 121.30% -7.90%   -216.58% -69.46% -33.75% -19.43% -16.50% -14.53% -13.32%  
      interest expense
    -2,900,000 -3,313,000 -4,043,000 -3,555,000 -3,344,000 -4,710,000 -4,002,000 -3,244,000   -1,932,000 -4,144,000   -1,430,000 -569,000 -574,000 -515,000 -630,000 -1,039,000 -1,191,000 -1,259,000 -1,361,000 -748,000 -1,007,000 -1,148,000 -1,240,000 -1,368,000 -1,281,000 -1,241,000 -1,240,000 -1,180,000 -1,252,000 -1,250,000 -1,261,000 -1,122,000 -970,000 -660,000 -950,000 -677,000 -743,000 -759,000 -544,000 -564,000 -504,000 -857,000 -970,000 -931,000 -729,000 -1,062,000 -873,000 -981,000 -770,500 -898,000                                -7,000 -9,000 -30,000 -23,000    -152,000 
      foreign currency gain
    -1,024,000 339,000 -17,432,000 -10,298,000 15,812,000 -8,480,000 -282,000 2,549,000 -6,302,000 2,107,000 346,000 -2,069,000 -5,262,000 -8,285,000 4,552,000 2,217,000 1,096,000 133,000 -515,000 773,000 123,000 -2,883,000  -938,000 -1,156,000 4,083,000 -804,000 203,000 -99,000 125,000 5,174,000  -1,188,000 -7,340,000 -13,251,000  7,722,000 -873,000 2,796,000 -1,835,000 373,000 420,000 -107,000 435,000 687,000 938,000 -320,000 -1,523,000 -714,000 -1,612,000 -889,000 987,000 -156,000 -421,000 3,289,000  5,795,000 2,006,000 1,235,000                                   
      other income
    -3,515,000   -1,124,000 -1,000 263,000 -284,000 973,000 -2,984,000 272,000 556,000 230,000 449,000 361,000 134,000 204,000 104,000 10,000 12,000 -9,000 -194,000 -615,000 2,882,000 264,000 -424,000 231,000 171,000 143,000 -411,000 212,000 215,000 1,089,000 -82,000 -403,000 173,000 236,000 -863,000 359,000 30,000 365,000 -683,000 487,000 262,000 195,000 -426,000 495,000 320,000 -19,000 288,000 191,000 164,000 336,000 292,000 313,000 239,000 79,000 -395,000 193,000 414,000 227,000 36,000 37,000 7,000 65,000 53,000 33,000 45,000 52,000 -1,000 25,000 35,000 52,000 40,000 39,000 50,000 50,000 50,000 21,000 50,000 50,000 50,000 51,000 50,000 50,000  49,000 56,000 53,000 50,000     
      earnings before income tax
    10,333,000 20,884,000 2,534,000 2,084,000 36,108,000 19,410,000 28,420,000 18,327,000 17,220,000 22,752,000 3,291,000 11,691,000 -4,262,000 15,611,000 10,991,000 16,042,000 22,507,000 20,332,000 30,539,000 40,474,000 40,645,000 33,749,000 -10,117,000 17,279,000 12,885,000 22,658,000 8,299,000 15,309,000 19,042,000 3,333,000 19,742,000 16,002,000 18,553,000 7,184,000 10,884,000 32,634,000 32,355,000 26,241,000 24,229,000 27,738,000 39,068,000 37,463,000 26,228,000 26,179,000 24,275,000 24,140,000 22,925,000 22,881,000 15,685,000 12,365,000 7,476,000 10,704,000 6,049,000 8,195,000 9,919,000 8,509,000 11,154,000 2,492,000 2,191,000 1,105,000 2,445,000 4,054,000 3,361,000 2,419,000 2,050,000 1,122,000 -1,160,000 -1,403,000 230,000 1,078,000 2,003,000 2,191,000 2,632,000 1,973,000 2,086,000 2,154,000 2,204,000 1,450,000 1,314,000 1,239,000              
      income tax expense
    7,346,000 5,935,000 2,057,000 2,212,000 20,787,000 3,445,000 9,544,000 3,542,000 -867,000 6,908,000 4,842,000 3,728,000 -57,000 5,784,000 3,919,000 4,295,000 2,459,000 4,646,000 5,748,000 7,565,000 6,652,000 9,603,000 205,000 5,406,000 2,431,000 6,771,000 5,548,000 6,895,000 6,413,000 3,688,000 3,083,000 3,036,000 23,795,000 630,000 2,371,000 7,232,000 6,319,000 6,018,000 5,783,000 15,845,000 10,654,000 9,798,000 6,734,000 6,359,000 4,446,000 6,852,000 6,502,000 6,302,000 4,754,000 3,600,000 1,948,000 795,000 771,000 2,425,000 2,911,000 2,244,000 9,170,000 -973,000 1,373,000 1,771,000 -691,000 1,492,000 1,244,000 876,000 750,000 333,000 -291,000 -467,000 -61,000 430,000 749,000 820,000   830,000 860,000 1,174,000 550,000 498,000 471,000              
      net income
    2,987,000 14,949,000 477,000 -128,000 15,321,000 15,965,000 18,876,000 14,785,000 18,087,000 15,844,000 -1,551,000 7,963,000 -4,205,000 9,827,000 7,072,000 11,747,000 20,048,000 15,686,000 24,791,000 32,909,000 33,993,000 24,146,000 -10,322,000 11,873,000 10,454,000 15,887,000 2,751,000 8,414,000 12,629,000 -355,000 16,659,000 12,966,000 -5,242,000 6,554,000 8,513,000 25,402,000 26,036,000 20,223,000 18,446,000 11,893,000 28,414,000 27,665,000 19,494,000 19,820,000 19,829,000 17,288,000 16,423,000 16,579,000 10,931,000 8,765,000 5,528,000 9,909,000 5,278,000 5,770,000 7,008,000 6,265,000 10,218,000 1,519,000 818,000 -666,000 3,136,000 2,562,000 2,117,000 1,543,000 1,300,000 789,000 -869,000 -936,000 291,000 648,000 1,254,000 1,371,000 1,769,000 3,056,000 1,256,000 1,294,000 1,030,000 900,000 816,000 768,000 14,755,000 878,000 454,000 462,000  265,000 -146,000 -609,000 -925,000 -1,141,000 -1,411,000 -1,655,000 -2,099,000 
      yoy
    -80.50% -6.36% -97.47% -100.87% -15.29% 0.76% -1317.02% 85.67% -530.13% 61.23% -121.93% -32.21% -120.97% -37.35% -71.47% -64.30% -41.02% -35.04% -340.18% 177.18% 225.17% 51.99% -475.21% 41.11% -17.22% -4575.21% -83.49% -35.11% -340.92% -105.42% 95.69% -48.96% -120.13% -67.59% -53.85% 113.59% -8.37% -26.90% -5.38% -39.99% 43.30% 60.02% 18.70% 19.55% 81.40% 97.24% 197.09% 67.31% 107.10% 51.91% -21.12% 58.16% -48.35% 279.86% 756.72% -1040.69% 225.83% -40.71% -61.36% -143.16% 141.23% 224.71% -343.61% -264.85% 346.74% 21.76% -169.30% -168.27% -83.55% -78.80% -0.16% 5.95% 71.75% 239.56% 53.92% 68.49% -93.02% 2.51% 79.74% 66.23%  231.32% -410.96% -175.86%  -123.23% -89.65% -63.20% -55.93%     
      qoq
    -80.02% 3033.96% -472.66% -100.84% -4.03% -15.42% 27.67% -18.26% 14.16% -1121.53% -119.48% -289.37% -142.79% 38.96% -39.80% -41.41% 27.81% -36.73% -24.67% -3.19% 40.78% -333.93% -186.94% 13.57% -34.20% 477.50% -67.30% -33.38% -3657.46% -102.13% 28.48% -347.35% -179.98% -23.01% -66.49% -2.44% 28.74% 9.63% 55.10% -58.14% 2.71% 41.92% -1.64% -0.05% 14.70% 5.27% -0.94% 51.67% 24.71% 58.56% -44.21% 87.74% -8.53% -17.67% 11.86% -38.69% 572.68% 85.70% -222.82% -121.24% 22.40% 21.02% 37.20% 18.69% 64.77% -190.79% -7.16% -421.65% -55.09% -48.33% -8.53% -22.50% -42.11% 143.31% -2.94% 25.63% 14.44% 10.29% 6.25% -94.79% 1580.52% 93.39% -1.73%   -281.51% -76.03% -34.16% -18.93% -19.14% -14.74% -21.15%  
      basic earnings per share
    0.1 0.49 0.02  0.5 0.51 0.6 0.47 0.56 0.48 -0.05 0.24 -0.13 0.3 0.21 0.36 0.6 0.47 0.75 1.04 0.74 -0.32 0.36 0.32 0.48 0.08 0.25 0.37 -0.01 0.46 0.35 -0.14 0.18 0.23 0.69 0.71 0.55 0.51 0.33 0.79 0.77 0.54 0.55 0.56 0.49 0.46 0.47 0.32 0.25 0.15 0.24 0.07 0.09 0.13 0.11 0.26 -0.07 -0.07 -0.03 0.15 0.12 0.11 0.08 0.06 0.05 -0.04 -0.04 0.038 0.03 0.06 0.06                      
      diluted earnings per share
    0.09 0.49 0.02  0.49 0.51 0.6 0.47 0.55 0.48 -0.05 0.24 -0.13 0.29 0.21 0.35 0.6 0.47 0.74 0.99 1.03 0.73 -0.32 0.36 0.32 0.48 0.08 0.25 0.36 -0.01 0.45 0.35 -0.14 0.18 0.23 0.69 0.71 0.55 0.5 0.33 0.78 0.76 0.53 0.55 0.55 0.48 0.46 0.47 0.31 0.24 0.15 0.24 0.08 0.09 0.12 0.11 0.26 -0.07 -0.07 -0.03 0.14 0.12 0.1 0.07 0.06 0.05 -0.04 -0.04 0.02 0.03 0.06 0.06         0.68 0.04 0.02 0.02          
      weighted-average number of shares – basic
    30,585 30,480 30,600 30,779 31,293 31,187 31,534 31,544 32,778 32,944 33,019 33,182 33,126 33,162 33,119 33,035 33,086 33,178 33,100 32,946 32,666 32,624 32,580 32,693 33,120 32,839 33,441 33,573  36,104 36,523 36,766  36,742 36,777 36,620  36,477 36,442 36,357  36,110 35,971 35,769  35,522 35,361 35,064  34,447 32,658 31,607  29,619 29,568 24,461  22,753 22,208 22,081  21,713 21,621 21,532  21,470 21,420 21,232  22,151 22,140 22,004                      
      weighted-average number of shares – diluted
    30,933 30,748 30,652 30,779 31,476 31,365 31,710 31,691 33,067 33,196 33,019 33,386 33,503 33,470 33,426 33,377 33,510 33,609 33,544 33,390 33,028 32,958 32,580 32,869 33,298 32,933 33,574 33,733  36,448 36,667 36,873  36,805 36,840 36,739  36,595 36,637 36,550  36,482 36,585 36,245  36,271 36,094 35,592  34,886 33,167 32,084  30,003 30,103 25,151  22,753 22,208 22,081  22,488 22,381 22,345  22,082 21,420 21,232  22,355 22,710 22,784  22,748 22,712 22,363  22,141 20,114 18,261  16,215 16,132 15,592          
      impairment of goodwill
              19,509,000                                                                                   
      interest income
            -2,361,000 -3,368,000   -321,250 714,000                                         -1,048,000 -1,136,000 -1,061,000 -1,213,000 -1,246,000 9,000 16,000 9,000 3,000 -3,000 -9,000 -7,000 4,000 22,000 123,000 199,000 218,000 297,000 280,000 251,000 244,000 186,000 158,000 135,000 119,000 111,000 93,000 79,000 66,000 45,000      162,000 1,000 9,000  
      gain on sale of business
                            1,242,500   4,970,000                                                                  
      impairment loss
                            -5,301,500 -837,000 -9,885,000 -10,484,000  -11,476,000                                                                
      foreign currency loss
                          -1,741,000         -4,578,000    -1,329,000                    -511,000                                      
      acquisition transaction expenses
                              342,000 38,000         50,000 22,000 634,000 37,000        1,075,000 503,000 326,000 422,000 1,163,000     -64,000 200,000 1,426,000 3,754,000                                  
      revaluation of derivatives
                                            -287,750 -134,000   -73,250 294,000 -340,000 -247,000 -195,000 217,000 638,000 346,000 -1,236,000 -993,000 -1,423,000 1,360,000 -544,000 -4,305,000 -1,269,000                                   
      selling, general and administrative
                                           22,624,000 17,886,500 22,543,000 24,058,000 24,945,000 15,592,000 22,307,000 21,972,000 18,089,000 13,370,750 18,319,000 18,908,000 16,256,000 11,493,000 16,560,000 15,439,000 13,973,000 6,523,000 13,545,000 9,183,000 3,364,000 1,862,250 2,498,000 2,491,000 2,460,000 1,579,750 2,004,000 2,166,000 2,149,000 1,541,000 2,005,000 2,032,000 2,127,000 2,247,000 2,119,000 2,023,000 2,153,000 2,309,000 1,869,000 1,848,000 1,594,000 1,265,000 1,267,000 1,464,000 1,466,000  1,293,000 1,387,000 1,346,000 1,084,000 1,510,000 1,497,000 1,333,000 1,213,000 
      revaluation of derivatives loss
                                              -53,000 -964,000                                                  
      debt retirement expense
                                                -640,000 -730,000           -190,000 -3,000 -967,000                                   
      gain from equity investment
                                                                                                 
      gain realized from step acquisition of subsidiary
                                                196,250   785,000                                              
      income from equity investment
                                                    79,750 77,000 17,000 225,000                                          
      income attributable to non-controlling interest
                                                       -1,258,000                                          
      net income attributable to gentherm incorporated
                                                12,572,500 17,288,000 16,423,000 16,579,000 5,715,500 8,702,000 5,509,000  3,638,000 4,098,000                                        
      convertible preferred stock dividends
                                                     -159,000 -540,000 -923,000 -1,190,000 -1,516,000 -1,840,000 -2,165,000 -2,490,000 -2,815,000 -2,923,000                                   
      net income attributable to common shareholders
                                                19,829,000 17,288,000 16,423,000 16,579,000 10,958,000 8,543,000 4,969,000 7,728,000 2,130,000 2,582,000 3,736,000 2,713,000 6,008,000 -1,644,000 -1,582,000                                   
      gain attributable to non-controlling interest
                                                    -335,000 -63,000 -19,000  -1,122,750 -1,672,000 -1,432,000 -1,387,000                                      
      net income attributable to gentherm, inc.
                                                       8,651,000                                          
      research and development
                                                        7,870,000 10,702,000 10,577,000 10,201,000 4,730,250 11,520,000 4,740,000 2,661,000 2,289,500 2,789,000 3,390,000 2,979,000 1,568,250 1,935,000 1,919,000 2,419,000 1,765,000 2,478,000 2,183,000 2,399,000 1,396,250 1,990,000 1,868,000 1,727,000 1,243,250 1,811,000 1,823,000 1,339,000 479,250 630,000 656,000 631,000  256,000 602,000 684,000 945,000 988,000 968,000 1,052,000 902,000 
      research and development reimbursements
                                                        -440,750 -656,000 -665,000 -442,000 -145,250 -235,000 -154,000 -192,000 -548,250 -490,000 -528,000 -1,175,000 -407,750 -613,000 -345,000 -673,000 -499,750 -504,000 -686,000 -809,000 -432,750 -619,000 -528,000 -584,000 -612,750 -815,000 -933,000 -703,000              
      net income attributable to amerigon, inc.
                                                          5,576,000 4,878,000 8,498,000 1,171,000 1,341,000 -666,000 1,662,000 2,691,000 2,307,000 1,650,000 -168,500 1,131,000                            
      (income) loss attributable to non-controlling interest
                                                            -1,720,000 -348,000                                    
      loss attributable to non-controlling interest
                                                              523,000                                   
      loss from equity investment
                                                                   -22,000 -369,000 -123,000                            
      plus: loss attributable to non-controlling interest
                                                                166,000 129,000 190,000 107,000 97,000 342,000                            
      income tax benefit
                                                                            151,750 -1,083,000                    
      basic earnings per share:
                                                                                                 
      common stock
                                                                            0.08 0.14 0.06 0.06 0.05 0.04 0.04 0.04 0.7 0.04 0.02 0.02          
      convertible preferred stock
                                                                                0.05  0.04 0.04 0.7 0.04 0.02 0.02          
      diluted earnings per common share
                                                                            0.063 0.13 0.06 0.06 0.028 0.04 0.04 0.03              
      operating costs and expenses:
                                                                                                 
      total operating costs and expenses
                                                                                3,154,000 2,865,000 2,738,000 2,230,000 1,981,000 1,897,000 2,120,000 2,097,000  1,546,000 1,989,000 2,030,000 2,029,000 2,498,000 2,465,000 2,385,000 2,115,000 
      minority interest in net income of subsidiary
                                                                                         500        
      basic and diluted net loss per share:
                                                                                               -0.15  
      loss before extraordinary item
                                                                                         -0.038 -0.01       
      weighted-average number of common shares outstanding
                                                                                          12,064 10,785   10,772 10,771  
      basic and diluted net loss per share
                                                                                           -0.06 -0.09 -0.135 -0.13  -0.3 
      minority interest in net loss of subsidiary
                                                                                            2,000 -8,000 6,000 -5,000  
      weighted-average number of shares outstanding
                                                                                         11,472   10,771 9,859   7,072 
      minority interest
                                                                                                -33,000 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 
                                                                                                 
        assets
                                                                                                 
        current assets:
                                                                                                 
        cash and cash equivalents
      160,833,000 154,250,000 128,297,000 163,142,000 134,134,000 150,581,000 123,466,000 125,107,000 149,673,000 154,354,000 168,671,000 166,630,000 153,891,000 139,163,000 157,258,000 177,917,000 190,606,000 195,086,000 186,863,000 170,955,000 268,345,000 226,533,000 209,170,000 222,939,000 50,443,000 45,200,000 33,677,000 38,769,000 39,620,000 47,152,000 65,357,000 70,482,000 103,172,000 147,626,000 164,177,000 133,907,000 177,187,000 132,813,000 132,007,000 210,556,000 144,479,000 129,172,000 101,643,000 79,581,000  65,169,000                                              
        accounts receivable
      281,083,000 291,293,000 294,719,000 284,241,000 258,112,000 270,913,000 264,759,000 265,149,000 253,579,000 263,765,000 258,157,000 256,715,000 247,131,000 248,570,000 207,364,000 207,351,000 182,987,000 182,324,000 198,225,000 222,385,000 211,672,000 193,249,000                                                                      
        inventory
      252,702,000 253,253,000 248,384,000 235,988,000 227,356,000 233,746,000 214,370,000 219,584,000 205,892,000 205,856,000 207,940,000 218,463,000 218,248,000 233,895,000 187,784,000 176,168,000 159,477,000 154,296,000 138,246,000 132,057,000 122,401,000 114,636,000 112,630,000 117,641,000 118,479,000 118,791,000 112,613,000 112,125,000 112,535,000 108,589,000 118,363,000 120,637,000 121,409,000 113,385,000 106,568,000 108,455,000 105,074,000 107,204,000 94,563,000 86,950,000 84,183,000 77,923,000 79,616,000 80,145,000 77,643,000 74,783,000 68,023,000 65,591,000 64,217,000 62,806,000 56,210,000 52,238,000 53,756,000 51,800,000 46,384,000 50,220,000 46,344,000 49,667,000 44,807,000 7,326,000 6,825,000 3,389,000 2,907,000 3,122,000 2,541,000 2,137,000 3,477,000 3,397,000 2,641,000 4,442,000 4,836,000 3,170,000 2,219,000 1,706,000 1,904,000 4,369,000 4,936,000 3,070,000 2,712,000    1,901,000 2,498,000 2,746,000 3,358,000 2,297,000 1,903,000 1,923,000 2,635,000 2,030,000 
        other current assets
      82,332,000 87,096,000 87,415,000 80,673,000 64,413,000 81,711,000 87,091,000 90,592,000 78,420,000 76,651,000 74,781,000 69,691,000 64,597,000 84,344,000 40,320,000 41,034,000 32,775,000 41,997,000 35,668,000 39,072,000 41,188,000 37,988,000 36,592,000 44,941,000 42,726,000                                                                   
        total current assets
      776,950,000 785,892,000 758,815,000 764,044,000 684,015,000 736,951,000 689,686,000 700,432,000 687,564,000 700,626,000 709,549,000 711,499,000 683,867,000 705,972,000 592,726,000 602,470,000 565,845,000 573,703,000 559,002,000 564,469,000 643,606,000 574,912,000 479,782,000 547,037,000 373,863,000 384,841,000 378,431,000 401,881,000 443,075,000 454,546,000 446,572,000 445,751,000 461,069,000 481,823,000 494,502,000 473,103,000 488,753,000 464,996,000 449,850,000 513,820,000 420,608,000 397,404,000 372,242,000 346,675,000 335,025,000 328,679,000 297,201,000 301,041,000 269,932,000 251,042,000 249,021,000 235,706,000 242,144,000 252,028,000 244,988,000 263,121,000 177,670,000 181,799,000 182,691,000 224,603,000 68,436,000 66,466,000 57,803,000 52,852,000 47,702,000 43,117,000 37,918,000 38,098,000 37,639,000 47,034,000 34,431,000 24,321,000 43,365,000 36,071,000 35,698,000 32,337,000 29,878,000 24,315,000 23,396,000 19,421,000 17,372,000 17,400,000 14,575,000 9,448,000 10,312,000 8,052,000 6,619,000 7,270,000 5,940,000 6,677,000 8,072,000 
        property and equipment
      270,614,000 256,948,000 262,419,000 253,169,000 252,970,000 253,531,000 246,304,000 241,798,000 245,234,000 236,660,000 239,920,000 242,143,000 244,480,000 228,056,000 149,907,000 152,288,000 155,270,000 155,788,000 155,439,000 151,440,000 152,581,000 150,801,000 149,240,000 152,120,000 160,605,000 162,783,000 169,345,000 168,371,000 171,380,000 189,005,000 203,949,000 205,232,000 200,294,000 190,825,000 187,391,000 179,848,000 172,052,000 167,336,000 158,019,000 131,332,000 119,157,000 108,539,000 101,804,000 92,444,000 91,727,000 88,760,000 84,158,000 78,901,000 79,234,000 73,608,000 64,704,000 56,900,000 55,010,000 50,702,000 46,342,000 45,484,000 44,794,000 43,423,000 43,701,000 4,507,000 4,197,000 4,142,000 4,419,000 4,638,000 3,271,000 3,231,000 3,934,000 4,100,000 4,274,000 4,561,000 4,562,000 4,524,000 3,965,000 2,570,000 1,914,000 1,986,000 1,756,000 1,453,000 1,177,000 1,090,000 1,233,000 1,305,000 1,385,000 1,300,000 1,445,000 1,531,000 1,447,000 1,324,000 1,524,000 1,338,000 1,263,000 
        goodwill
      108,918,000 108,730,000 108,891,000 102,431,000 99,603,000 104,839,000 101,822,000 102,194,000 104,073,000 100,633,000 100,885,000 120,955,000 119,774,000 125,273,000 62,935,000 64,979,000 66,033,000 66,769,000 66,710,000 66,289,000 68,024,000 66,266,000 64,629,000 63,894,000 64,572,000 63,501,000 65,114,000 54,721,000 55,311,000 55,705,000 68,845,000 70,439,000 69,685,000 54,287,000 53,497,000 52,031,000 51,735,000 52,935,000 51,009,000 28,826,000 27,765,000 28,523,000 28,472,000 27,673,000 30,398,000 30,264,000 32,247,000 25,830,000 25,809,000 25,300,000 24,362,000 24,004,000 24,729,000 24,076,000 23,555,000 24,982,000 24,245,000 24,802,000 25,454,000                                 
        other intangible assets
      52,796,000 54,291,000 56,076,000 56,288,000 57,251,000 61,067,000 62,082,000 63,165,000 66,482,000 66,427,000 69,096,000 72,051,000 73,933,000 68,639,000 31,968,000 34,982,000 37,554,000 39,140,000 41,009,000 42,859,000 46,421,000 47,429,000 48,399,000 50,062,000  51,338,000 55,479,000 53,188,000  60,202,000 73,574,000 80,809,000  52,520,000 54,356,000 55,219,000  62,947,000 65,814,000 47,972,000  52,977,000 56,916,000 58,171,000  77,277,000 87,239,000 81,637,000  85,827,000 86,710,000 89,279,000  103,193,000 97,983,000 107,472,000  118,288,000 130,822,000                                 
        operating lease right-of-use assets
      56,524,000 58,662,000 59,510,000 57,550,000 43,954,000 29,366,000 30,631,000 34,631,000 27,358,000 27,442,000 29,925,000 31,024,000 29,945,000 30,214,000 25,924,000 27,445,000 24,387,000 24,718,000 26,195,000 27,200,000 30,642,000 18,844,000 12,780,000 14,991,000 11,587,000 12,136,000 13,267,000 14,058,000                                                                
        deferred income tax assets
      93,552,000 78,302,000 78,336,000 75,867,000 75,041,000 81,923,000 80,264,000 81,395,000 81,930,000 73,177,000 74,537,000 73,004,000 69,840,000 66,322,000 67,112,000 69,420,000 69,630,000 67,307,000 72,558,000 71,983,000 73,912,000 55,641,000 57,972,000 56,032,000 57,650,000 54,380,000 60,071,000 61,032,000 64,024,000 73,221,000 82,762,000 84,946,000 30,152,000 44,564,000 37,805,000 35,931,000 35,299,000 7,335,000 7,271,000 7,449,000 6,716,000 5,714,000 5,738,000 5,532,000 6,247,000 10,149,000 10,700,000 10,448,000 10,616,000 14,389,000 13,450,000 13,718,000 15,006,000 9,273,000 9,283,000 9,160,000 12,732,000 1,286,000 1,717,000 1,460,000 4,905,000 2,605,000 2,762,000 2,330,000 927,000 740,000 956,000 744,000 986,000 4,170,000 4,121,000 3,935,000 3,784,000 3,762,000 3,691,000 3,839,000 2,654,000 2,316,000 1,447,000             
        other non-current assets
      37,075,000 38,510,000 37,354,000 34,897,000 34,722,000 30,502,000 29,764,000 29,095,000 21,730,000 20,632,000 20,135,000 18,070,000 17,461,000 16,857,000 16,474,000 15,529,000 16,624,000 16,553,000 12,960,000 8,214,000 7,653,000 7,554,000 10,568,000 9,234,000 9,326,000 7,000,000 8,421,000 9,220,000 12,225,000 11,617,000 13,500,000 13,371,000 37,983,000 37,561,000 37,867,000 35,397,000 36,413,000 38,608,000 38,561,000 38,297,000 8,403,000 12,363,000 12,125,000 11,126,000 12,019,000 11,140,000 11,599,000 11,479,000 13,373,000 10,701,000 10,078,000 9,866,000 10,062,000 9,928,000 9,197,000 9,555,000 8,774,000 3,172,000 2,346,000 887,000 857,000 857,000 541,000 543,000 527,000 465,000 195,000 196,000 196,000 257,000                      
        total assets
      1,396,429,000 1,381,335,000 1,361,401,000 1,344,246,000 1,247,556,000 1,298,179,000 1,240,553,000 1,252,710,000 1,234,371,000 1,225,597,000 1,244,047,000 1,268,746,000 1,239,300,000 1,241,333,000 947,046,000 967,113,000 935,343,000 943,978,000 933,873,000 932,454,000 1,022,839,000 921,447,000 823,370,000 893,370,000 727,386,000 737,671,000 751,910,000 763,046,000 803,047,000 845,029,000 890,013,000 901,423,000 883,405,000 862,588,000 866,497,000 832,678,000 843,030,000 809,553,000 787,576,000 786,535,000 646,798,000 625,688,000 599,754,000 563,294,000 557,892,000 557,673,000 534,836,000 513,337,000 481,923,000 457,899,000 446,467,000 427,192,000 439,197,000 458,537,000 443,791,000 465,539,000 377,807,000 402,808,000 419,361,000 243,257,000 79,422,000 77,944,000 70,355,000 67,060,000 62,382,000 58,999,000 53,710,000 53,743,000 52,599,000 58,675,000 59,078,000 58,736,000 55,986,000 46,859,000 45,104,000 42,396,000 42,576,000 37,188,000 37,253,000 20,997,000 19,097,000 19,084,000 16,293,000 11,234,000 12,123,000 10,022,000 8,578,000 9,179,000 8,122,000 8,746,000 10,140,000 
        liabilities and shareholders’ equity
                                                                                                 
        current liabilities:
                                                                                                 
        accounts payable
      260,487,000 263,600,000 254,133,000 243,224,000 226,815,000 254,555,000 222,039,000 226,190,000 215,827,000 213,851,000 207,655,000 207,887,000 182,225,000 208,338,000 147,136,000 156,236,000 122,727,000 124,000,000 115,096,000 132,831,000 116,043,000 108,452,000 65,521,000 97,065,000 83,035,000 89,293,000 84,009,000 91,286,000 93,113,000 88,991,000 95,022,000 88,087,000 89,596,000 80,322,000 83,719,000 86,156,000 84,511,000 88,814,000 83,949,000 84,880,000 77,115,000 70,386,000 82,869,000 84,544,000 71,434,000 73,638,000 64,907,000 66,198,000 61,662,000 55,176,000 58,958,000 42,961,000 42,508,000 43,270,000 41,130,000 43,402,000 42,533,000 48,815,000 39,400,000 19,337,000 15,275,000 16,711,000 12,872,000 12,500,000 10,222,000 9,310,000 5,381,000 4,358,000 3,872,000 6,689,000 8,238,000 9,799,000 8,640,000 6,210,000 6,890,000 5,615,000 7,628,000 4,926,000 5,323,000 3,866,000 3,529,000 4,214,000 3,199,000 4,258,000 5,457,000 3,979,000 3,674,000 4,296,000 2,368,000 2,274,000 1,751,000 
        current lease liabilities
      9,646,000 10,181,000 9,913,000 9,535,000 7,517,000 7,038,000 7,087,000 7,642,000 7,700,000 7,633,000 8,005,000 8,093,000 7,143,000 7,448,000 5,376,000 5,920,000 5,669,000 5,948,000 6,046,000 6,168,000 6,032,000 5,206,000 4,184,000 4,735,000 4,586,000 4,483,000 5,031,000 4,203,000                                                                
        current maturities of long-term debt
      73,000 109,000 146,000 138,000 137,000 210,000 268,000 324,000 621,000 620,000 684,000 1,996,000 2,443,000 3,540,000 2,500,000 2,500,000 2,500,000 2,500,000 2,500,000 2,500,000 2,500,000 2,500,000 2,500,000 2,500,000 2,500,000 2,500,000 2,955,000 2,949,000 3,413,000 3,429,000 3,433,000 3,485,000 3,460,000 3,445,000 3,414,000 2,105,000 2,092,000 899,000 889,000 912,000 4,909,000 4,510,000 4,505,000 4,657,000 5,306,000 4,816,000 19,519,000 20,566,000 21,439,000 22,164,000 22,598,000 22,509,000 17,218,000 18,172,000 15,091,000 15,309,000 14,570,000 15,277,000 18,251,000                                 
        other current liabilities
      134,104,000 126,435,000 112,733,000 100,333,000 105,824,000 103,647,000 96,724,000 98,939,000 100,805,000 90,199,000 91,278,000 88,896,000 93,814,000 100,898,000 84,206,000 79,044,000 82,193,000 82,905,000 83,500,000 81,251,000 81,409,000 74,443,000 63,805,000 67,000,000 66,583,000                                                                   
        total current liabilities
      404,310,000 400,325,000 376,925,000 353,230,000 340,293,000 365,450,000 326,118,000 333,095,000 324,953,000 312,303,000 307,622,000 306,872,000 285,625,000 320,224,000 239,218,000 243,700,000 213,089,000 215,353,000 207,142,000 222,750,000 205,984,000 190,601,000 136,010,000 171,300,000 156,704,000 170,500,000 161,415,000 166,354,000 175,396,000 178,437,000 171,690,000 164,481,000 171,315,000 149,286,000 153,079,000 153,157,000 193,623,000 202,103,000 203,322,000 182,537,000 143,783,000 146,526,000 155,663,000 149,514,000 147,593,000 151,355,000 156,301,000 156,284,000 153,146,000 137,688,000 137,608,000 122,305,000 117,209,000 133,009,000 117,188,000 117,023,000 111,715,000 116,937,000 112,035,000 121,188,000 21,197,000 21,050,000 17,246,000 16,535,000 14,160,000 12,511,000 8,416,000 8,214,000 7,168,000 10,532,000 11,964,000 13,209,000 12,827,000 9,571,000 9,333,000 8,572,000 10,273,000 6,884,000 7,750,000 6,257,000 5,572,000 5,954,000 5,004,000 5,326,000 7,201,000 5,277,000 6,432,000 6,056,000 3,973,000 3,131,000 2,766,000 
        long-term debt, less current maturities
      189,000,000 189,000,000 209,000,000 262,034,000 220,064,000 222,104,000 222,134,000 222,173,000 222,217,000 207,302,000 217,441,000 232,558,000 232,653,000 232,000,000 35,000,000 36,250,000 36,250,000 37,500,000 45,794,000 59,319,000 189,934,000 193,061,000 198,099,000 231,667,000 78,124,000 97,123,000 104,393,000 97,604,000 136,477,000 98,000,000 109,467,000 105,742,000 141,209,000 142,446,000 159,871,000 161,032,000 169,433,000 140,673,000 141,098,000 172,524,000 92,832,000 94,781,000 81,078,000 81,126,000 85,469,000 89,976,000 65,727,000 69,762,000 60,881,000 65,270,000 70,230,000 69,314,000 39,734,000 42,110,000 45,358,000 58,308,000 61,677,000 66,048,000 72,863,000                                 
        non-current lease liabilities
      48,105,000 49,678,000 51,135,000 50,795,000 37,052,000 21,929,000 21,920,000 23,126,000 16,175,000 16,451,000 18,095,000 19,740,000 20,538,000 22,013,000 18,721,000 19,978,000 19,789,000 20,313,000 21,275,000 22,354,000 24,233,000 15,046,000 10,097,000 10,869,000 6,751,000 7,391,000 7,741,000 9,307,000                                                                
        pension benefit obligation
      3,748,000 3,880,000 3,906,000 3,745,000 4,017,000 2,805,000 2,758,000 2,768,000 3,209,000 3,165,000 3,229,000 3,326,000 3,638,000 5,850,000 6,116,000 6,362,000 6,832,000 7,531,000 7,644,000 7,612,000 8,163,000 7,864,000 7,690,000 7,619,000 8,057,000 6,596,000 6,765,000 6,755,000  7,312,000 7,372,000 7,965,000  8,170,000 7,937,000 7,571,000  6,933,000 6,805,000 6,811,000  9,977,000 9,867,000 9,515,000 10,321,000 6,926,000 7,189,000 7,036,000 6,868,000 4,961,000 4,858,000 4,862,000 5,009,000 3,548,000 3,600,000 3,846,000 3,872,000 3,600,000 3,825,000 764,000 688,000 565,000 502,000 439,000 377,000 284,000 236,000 189,000 142,000 95,000 47,000                     
        other non-current liabilities
      30,943,000 20,504,000 20,690,000 27,914,000 29,183,000 25,182,000 27,319,000 24,489,000 23,095,000 26,324,000 27,100,000 25,932,000 24,573,000 37,157,000 4,796,000 5,036,000 5,577,000 7,801,000 6,808,000 7,661,000 8,194,000 3,079,000 2,153,000 1,534,000 3,743,000 3,326,000 3,738,000 2,890,000                                                                
        total liabilities
      676,106,000 663,387,000 661,656,000 697,718,000 630,609,000 637,470,000 600,249,000 605,651,000 589,649,000 565,545,000 573,487,000 588,428,000 567,027,000 617,244,000 303,851,000 311,326,000 281,537,000 288,498,000 288,663,000 319,696,000 436,508,000 409,651,000 354,049,000 422,989,000 254,736,000 286,078,000 286,629,000 284,559,000 323,348,000 294,708,000 301,587,000 290,975,000 329,531,000 311,783,000 333,529,000 335,419,000 382,625,000 364,439,000 366,883,000 379,222,000 262,507,000 273,306,000 272,906,000 265,658,000 263,673,000 277,555,000 262,256,000 261,787,000 249,829,000 242,253,000 247,807,000 233,417,000 201,565,000 216,924,000 204,725,000 219,953,000 219,994,000 235,568,000 247,465,000 121,952,000 21,885,000 21,615,000 17,748,000 16,974,000 14,587,000 12,895,000 8,802,000 8,603,000 7,560,000 10,927,000 12,361,000 13,609,000 13,277,000 10,121,000 9,933,000 9,222,000 10,973,000 7,684,000 8,600,000 7,157,000 6,522,000 6,954,000 6,054,000 6,595,000 8,501,000 6,627,000 7,832,000 7,508,000 5,473,000 4,686,000 4,399,000 
        shareholders’ equity:
                                                                                                 
        common stock:
                                                                                                 
        no par value; 55,000,000 shares authorized 30,526,231 and 30,788,639 issued and outstanding at december 31, 2025 and december 31, 2024, respectively
      5,611,000                                                                                           
        paid-in capital
      1,590,000 1,590,000 1,590,000 4,290,000 4,290,000 4,552,000 4,949,000   5,379,000 5,379,000 5,379,000 5,447,000 5,477,000 5,720,000 5,720,000 5,866,000 5,980,000 6,162,000 6,123,000 7,458,000 9,798,000 9,770,000 9,648,000 10,852,000 11,348,000 14,020,000 14,513,000 14,934,000 14,293,000 15,838,000 16,155,000 15,625,000 14,206,000 12,166,000 11,176,000 10,323,000 1,460,000 221,000 -920,000 -1,282,000 -6,690,000 -6,530,000 -8,185,000 -8,224,000 -6,329,000 -5,820,000 -7,678,000 -9,582,000 -9,076,000 -7,621,000 -7,166,000 24,120,000 25,383,000 24,775,000 23,969,000 23,489,000 23,706,000 22,659,000 21,344,000 20,128,000 24,612,000 24,545,000 24,217,000 23,986,000 23,652,000 23,327,000 22,994,000 22,720,000 22,528,000 22,201,000 21,983,000 21,766,000 21,424,000 21,242,000 21,024,000 20,519,000 20,300,000 20,202,000 20,202,000 20,202,000 20,202,000 20,202,000 20,180,000 19,974,000 19,814,000 19,504,000 19,504,000 19,363,000 19,363,000 19,363,000 
        accumulated other comprehensive loss
      -964,000   -56,881,000 -85,193,000 -35,021,000 -55,699,000 -45,195,000 -30,160,000 -55,955,000 -37,413,000 -36,101,000 -46,489,000 -96,051,000 -68,648,000 -45,728,000 -36,922,000 -32,117,000 -24,176,000 -28,656,000 -14,982,000 -32,486,000 -47,845,000 -54,931,000 -42,441,000 -54,814,000 -39,440,000 -43,152,000 -39,500,000 -33,877,000 -31,843,000 -7,551,000  -25,223,000 -37,608,000 -61,393,000  -47,830,000 -49,500,000 -41,385,000  -45,459,000 -40,528,000 -45,063,000  -21,204,000 -7,505,000 -7,154,000   -18,059,000 -18,463,000  -13,513,000                                      
        accumulated earnings
      714,086,000 711,099,000 696,150,000 695,673,000 695,801,000 680,480,000 664,515,000 638,985,000 624,379,000 612,913,000 597,069,000 598,620,000 590,657,000 594,862,000 585,035,000 577,963,000 566,216,000 546,168,000 530,482,000 505,691,000 472,782,000 427,429,000 403,283,000 413,605,000 401,732,000 391,278,000 375,391,000 372,640,000 363,965,000 351,336,000 351,691,000 335,032,000 293,645,000 298,887,000 292,333,000 283,820,000 256,922,000 230,886,000 210,663,000 192,217,000 180,324,000 151,910,000 124,245,000 104,751,000 84,931,000 65,102,000 47,814,000 31,391,000 14,812,000 3,854,000                                          
        total shareholders’ equity
      720,323,000 717,948,000 699,745,000 646,528,000 616,947,000 660,709,000 640,304,000 647,059,000 644,722,000 660,052,000 670,560,000 680,318,000 672,273,000 624,089,000 643,195,000 655,787,000 653,806,000 655,480,000 645,210,000 612,758,000 586,331,000 511,796,000 469,321,000 470,381,000 472,650,000 451,593,000 465,281,000 478,487,000 479,699,000 550,321,000 588,426,000 610,448,000 553,874,000 550,805,000 532,968,000 497,259,000 460,405,000 445,114,000 420,693,000 407,313,000 384,291,000 352,382,000 326,848,000 297,636,000 294,219,000 280,118,000 272,580,000 251,550,000 232,094,000 215,646,000 191,851,000 180,248,000 215,163,000 211,980,000 202,435,000 202,136,000 107,715,000 110,651,000 108,965,000 59,840,000 57,537,000 56,329,000 52,607,000 50,086,000 47,795,000 46,104,000 44,908,000 45,140,000 45,039,000 47,748,000 46,717,000 45,127,000 42,709,000 36,738,000 35,171,000 33,174,000 31,603,000 29,504,000 28,653,000 13,840,000 12,575,000 12,130,000 10,239,000 4,639,000 3,622,000 3,395,000 746,000 1,671,000 2,649,000 4,060,000 5,741,000 
        total liabilities and shareholders’ equity
      1,396,429,000 1,381,335,000 1,361,401,000 1,344,246,000 1,247,556,000 1,298,179,000 1,240,553,000 1,252,710,000 1,234,371,000 1,225,597,000 1,244,047,000 1,268,746,000 1,239,300,000 1,241,333,000 947,046,000 967,113,000 935,343,000 943,978,000 933,873,000 932,454,000 1,022,839,000 921,447,000 823,370,000 893,370,000 727,386,000 737,671,000 751,910,000 763,046,000 803,047,000 845,029,000 890,013,000 901,423,000 883,405,000 862,588,000 866,497,000 832,678,000 843,030,000 809,553,000 787,576,000 786,535,000 646,798,000 625,688,000 599,754,000 563,294,000 557,892,000 557,673,000 534,836,000 513,337,000 481,923,000 457,899,000 446,467,000 427,192,000 439,197,000 458,537,000 443,791,000 465,539,000 377,807,000 402,808,000 419,361,000 243,257,000 79,422,000 77,944,000 70,355,000 67,060,000 62,382,000 58,999,000 53,710,000 53,743,000 52,599,000 58,675,000 59,078,000 58,736,000 55,986,000 46,859,000 45,104,000 42,396,000 42,576,000 37,188,000 37,253,000 20,997,000 19,097,000 19,084,000 16,293,000 11,234,000 12,123,000 10,022,000 8,578,000 9,179,000 8,122,000 8,746,000 10,140,000 
        inventory:
                                                                                                 
        raw materials
       136,014,000 130,029,000 143,275,000  141,547,000 129,752,000 134,463,000  122,919,000 129,972,000 137,829,000  154,273,000 122,371,000 111,621,000  89,017,000 80,208,000 74,549,000  62,970,000 61,762,000 60,844,000  65,337,000 66,181,000 66,316,000  61,770,000 65,686,000 64,871,000  59,399,000 58,364,000 59,425,000  64,185,000 58,391,000 53,394,000  47,350,000 49,559,000 51,404,000  46,168,000 43,409,000 43,243,000  35,388,000 32,368,000 26,802,000  29,975,000 28,812,000 31,752,000          14,000 140,000 337,000  197,000 71,000 168,000  164,000 398,000  919,000 1,924,000  1,842,000 1,610,000 961,000          
        work in process
       35,040,000 40,466,000 21,455,000  20,116,000 17,890,000 18,611,000  16,745,000 15,673,000 17,091,000  17,157,000 8,989,000 10,991,000  12,460,000 9,369,000 8,423,000  7,708,000 6,575,000 6,778,000  6,863,000 6,660,000 4,830,000  6,671,000 13,251,000 13,807,000  19,382,000 15,704,000 17,070,000  12,909,000 10,068,000 4,870,000  4,503,000 4,905,000 4,508,000  4,322,000 2,943,000 2,870,000  2,720,000 2,696,000 2,924,000  2,416,000 2,187,000 2,343,000                                    
        finished goods
       82,199,000 77,889,000 71,258,000  72,083,000 66,728,000 66,510,000  66,192,000 62,295,000 63,543,000  62,465,000 56,424,000 53,556,000  52,819,000 48,669,000 49,085,000  43,958,000 44,293,000 50,019,000  46,591,000 39,772,000 40,979,000  40,148,000 39,426,000 41,959,000  34,604,000 32,500,000 31,960,000  30,110,000 26,104,000 28,686,000  26,070,000 25,152,000 24,233,000  24,293,000 21,671,000 19,478,000  24,698,000 21,146,000 22,512,000  19,409,000 15,385,000 16,125,000          2,123,000 3,337,000 3,060,000  4,245,000 4,765,000 3,002,000  1,542,000 1,506,000  4,017,000 1,146,000  372,000 121,000 686,000          
        no par value; 55,000,000 shares authorized 30,525,148 and 30,788,639 issued and outstanding at september 30, 2025 and december 31, 2024, respectively
       3,901,000                                                                                          
        accumulated other comprehensive income
       1,358,000 2,005,000                              -20,444,000    -69,091,000    -51,670,000    -25,743,000    -5,203,000 -9,308,000   -11,231,000  -16,643,000 -11,017,000 -14,754,000 -3,995,000 2,903,000 985,000 93,000 127,000 86,000 56,000 59,000                           
        no par value; 55,000,000 shares authorized 30,519,826 and 30,788,639 issued and outstanding at june 30, 2025 and december 31, 2024, respectively
                                                                                                 
        no par value; 55,000,000 shares authorized 30,859,119 and 30,788,639 issued and outstanding at march 31, 2025 and december 31, 2024, respectively
         3,446,000                                                                                        
        no par value; 55,000,000 shares authorized 30,788,639 and 31,542,001 issued and outstanding at december 31, 2024 and december 31, 2023, respectively
          2,049,000                                                                                       
        no par value; 55,000,000 shares authorized 30,976,821 and 31,542,001 issued and outstanding at september 30, 2024 and december 31, 2023, respectively
           10,698,000                                                                                      
        no par value; 55,000,000 shares authorized 31,318,444 and 31,542,001 issued and outstanding at june 30, 2024 and december 31, 2023, respectively
            26,539,000                                                                                     
        no par value; 55,000,000 shares authorized 31,629,224 and 31,542,001 issued and outstanding at march 31, 2024 and december 31, 2023, respectively
             53,269,000                                                                                    
        no par value; 55,000,000 shares authorized 31,542,001 and 33,202,082 issued and outstanding at december 31, 2023 and december 31, 2022, respectively
              50,503,000                                                                                   
        no par value; 55,000,000 shares authorized 32,795,093 and 33,202,082 issued and outstanding at september 30, 2023 and december 31, 2022, respectively
               97,715,000                                                                                  
        no par value; 55,000,000 shares authorized 32,987,809 and 33,202,082 issued and outstanding at june 30, 2023 and december 31, 2022, respectively
                105,525,000                                                                                 
        no par value; 55,000,000 shares authorized 33,126,702 and 33,202,082 issued and outstanding at march 31, 2023 and december 31, 2022, respectively
                 112,420,000                                                                                
        no par value; 55,000,000 shares authorized 33,202,082 and 33,008,185 issued and outstanding at december 31, 2022 and december 31, 2021, respectively
                  122,658,000                                                                               
        no par value; 55,000,000 shares authorized 33,196,404 and 33,008,185 issued and outstanding at september 30, 2022 and december 31, 2021, respectively
                   119,801,000                                                                              
        no par value; 55,000,000 shares authorized 33,132,691 and 33,008,185 issued and outstanding at june 30, 2022 and december 31, 2021, respectively
                    121,088,000                                                                             
        no par value; 55,000,000 shares authorized 33,127,531 and 33,008,185 issued and outstanding at march 31, 2022 and december 31, 2021, respectively
                     117,832,000                                                                            
        no par value; 55,000,000 shares authorized 33,008,185 and 32,921,341 issued and outstanding at december 31, 2021 and december 31, 2020, respectively
                      118,646,000                                                                           
        no par value; 55,000,000 shares authorized 33,224,779 and 32,921,341 issued and outstanding at september 30, 2021 and december 31, 2020, respectively
                       135,449,000                                                                          
        no par value; 55,000,000 shares authorized 33,145,066 and 32,921,341 issued and outstanding at june 30, 2021 and december 31, 2020, respectively
                        132,742,000                                                                         
        no par value; 55,000,000 shares authorized 33,110,644 and 32,921,341 issued and outstanding at march 31, 2021 and december 31, 2020, respectively
                         129,600,000                                                                        
        restricted cash
                           2,506,000 2,505,000 2,505,000 2,505,000 2,504,000 2,504,000 2,500,000                               472,000 182,002,000                             78,000 320,000 503,000 
        no par value; 55,000,000 shares authorized 32,921,341 and 32,674,354 issued and outstanding at december 31, 2020 and december 31, 2019, respectively
                          121,073,000                                                                       
        no par value; 55,000,000 shares authorized 32,680,013 and 32,674,354 issued and outstanding at september 30, 2020 and december 31, 2019, respectively
                           107,055,000                                                                      
        accounts receivables
                            118,885,000 159,011,000 159,710,000 170,823,000 171,640,000 175,044,000 166,858,000 183,476,000 200,024,000 196,616,000 185,058,000 182,236,000 181,273,000 185,279,000 170,084,000 178,965,000 168,304,000 161,690,000 142,610,000 155,922,000 149,426,000 147,545,000 136,183,000 147,061,000 145,957,000 139,083,000 118,283,000 122,330,000 113,823,000 107,962,000 102,261,000 101,044,000 94,342,000 89,905,000 82,395,000 90,327,000 79,507,000 25,661,000 18,940,000 23,508,000 20,915,000 17,611,000 15,073,000 14,734,000 6,807,000 8,678,000 8,292,000 11,347,000 11,282,000 12,766,000 11,672,000 10,953,000 11,351,000 9,329,000 11,913,000 7,844,000 7,891,000 7,177,000 5,258,000 7,066,000 4,763,000 5,882,000 7,110,000 3,847,000  4,530,000  2,135,000  
        no par value; 55,000,000 shares authorized 32,639,752 and 32,674,354 issued and outstanding at june 30, 2020 and december 31, 2019, respectively
                            104,113,000                                                                     
        no par value; 55,000,000 shares authorized, 32,598,854 and 32,674,354 issued and outstanding at march 31, 2020 and december 31, 2019, respectively
                             102,059,000                                                                    
        assets held for sale
                               6,742,000 6,714,000 17,009,000 69,699,000 56,184,000                            9,127,000 10,534,000                                 
        other intangible assets, net of accumulated amortization of 89,112 and 81,198, respectively
                              49,783,000                                                                   
        liabilities held for sale
                               6,742,000 6,714,000 7,009,000 13,062,000 13,473,000                                                              
        deferred income tax liabilities
                              1,357,000 1,142,000 2,577,000 1,649,000  3,471,000 5,636,000 6,028,000  6,674,000 7,287,000 8,544,000  11,623,000 12,238,000 12,865,000 211,000 10,579,000 9,636,000 11,026,000  669,000 705,000 710,000 710,000 21,945,000 21,983,000 22,180,000                                        
        no par value; 55,000,000 shares authorized, 32,674,354 and 33,856,629 issued and outstanding at december 31, 2019 and december 31, 2018, respectively
                              102,507,000                                                                   
        derivative financial instruments
                               897,000 1,155,000 857,000 92,000 1,299,000  1,168,000 213,000 1,542,000 2,545,000 1,594,000 18,000 806,000 242,000 1,324,000  1,556,000 2,195,000 2,362,000 145,000 145,000 325,000 345,000 67,000 292,000 123,000 148,000 160,000 590,000 1,493,000 1,795,000 2,675,000 3,177,000 7,409,000 2,675,000                                
        prepaid expenses and other assets
                               39,884,000 50,128,000 55,577,000 54,271,000 57,846,000 62,828,000 56,848,000 51,217,000 37,034,000 39,939,000 43,868,000 36,390,000 38,679,000 47,463,000 45,851,000 42,620,000 27,117,000 33,624,000 31,510,000 29,107,000 31,372,000 29,042,000 27,923,000 21,864,000 15,222,000 16,014,000 13,663,000 12,809,000 17,042,000 16,192,000 11,440,000 9,685,000 11,153,000 10,610,000 1,570,000 1,421,000 1,517,000 1,181,000 680,000 780,000 602,000 511,000 94,000 417,000 366,000 583,000 737,000 595,000 1,251,000 316,000 284,000 106,000 54,000 7,000 326,000 411,000 287,000 308,000 224,000 412,000 393,000 398,000 563,000 413,000 247,000 155,000 
        deferred financing costs
                               1,692,000 1,782,000 575,000 647,000 733,000 811,000 875,000 936,000 1,008,000 1,079,000 1,149,000 1,221,000 849,000 896,000 931,000 310,000 333,000 356,000 377,000 406,000 1,054,000 945,000 1,059,000 1,072,000 1,246,000 1,457,000 1,616,000 1,880,000 1,789,000 2,029,000 2,250,000 2,441,000 3,291,000 3,555,000 4,024,000           7,000 8,000 9,000 11,000 11,000 12,000 13,000 15,000 16,000             
        accrued liabilities
                               67,482,000 62,706,000 60,907,000 65,808,000 72,544,000 72,781,000 72,908,000 77,209,000 65,519,000 65,946,000 64,896,000 105,625,000 111,355,000 117,941,000 96,078,000 60,823,000 66,067,000 62,972,000 55,496,000 68,387,000 69,288,000 68,394,000 65,996,000 66,783,000 57,696,000 53,315,000 53,762,000 54,157,000 68,212,000 57,172,000 51,489,000 46,293,000 47,809,000 51,392,000 11,943,000 5,872,000 4,239,000 4,224,000 3,835,000 3,738,000 3,001,000 2,835,000 2,356,000 3,096,000 3,643,000 3,526,000 3,210,000 3,987,000 3,161,000 2,243,000 2,757,000 2,445,000 1,758,000 2,227,000 2,191,000 1,843,000 1,540,000 1,605,000 868,000 1,018,000 707,000 994,000 890,000 904,000 657,000 815,000 
        no par value; 55,000,000 shares authorized, 32,741,826 and 33,856,629 issued and outstanding at september 30, 2019 and december 31, 2018, respectively
                               103,781,000                                                                  
        no par value; 55,000,000 shares authorized, 33,147,567 and 33,856,629 issued and outstanding at june 30, 2019 and december 31, 2018, respectively
                                115,310,000                                                                 
        no par value; 55,000,000 shares authorized, 33,653,179 and 33,856,629 issued and outstanding at march 31, 2019 and december 31, 2018, respectively
                                 134,486,000                                                                
        other intangible assets, net of accumulated amortization of 81,198 and 77,622, respectively
                                  56,385,000                                                               
        pension benefit obligations
                                  7,211,000    7,913,000    7,419,000    6,545,000                                                   
        other liabilities
                                  3,087,000 7,488,000 7,422,000 6,759,000 2,747,000 5,207,000 5,355,000 5,115,000 4,092,000 3,107,000 3,420,000 4,485,000 5,026,000 5,502,000 7,163,000 5,460,000 2,788,000 3,419,000 4,533,000 2,770,000 1,601,000 2,836,000 3,124,000 4,146,000 4,540,000 3,788,000 1,917,000 1,926,000                                    
        deferred tax liabilities
                                  1,177,000    6,347,000    8,058,000 229,000 223,000 238,000 14,321,000 20,000 21,000  10,804,000    17,975,000       3,316,000 3,218,000 30,685,000 36,269,000                                 
        no par value; 55,000,000 shares authorized, 33,856,629 and 36,761,362 issued and outstanding at december 31, 2018 and 2017, respectively
                                  140,300,000                                                               
        no par value; 55,000,000 shares authorized, 35,748,829 and 36,761,362 issued and outstanding at september 30, 2018 and december 31, 2017, respectively
                                   218,569,000                                                              
        no par value; 55,000,000 shares authorized, 36,400,971 and 36,761,362 issued and outstanding at june 30, 2018 and december 31, 2017, respectively
                                    252,740,000                                                             
        no par value; 55,000,000 shares authorized, 36,794,573 and 36,761,362 issued and outstanding at march 31, 2018 and december 31, 2017, respectively
                                     266,812,000                                                            
        other intangible assets, net of accumulated amortization of 77,622 and 53,965, respectively
                                      83,286,000                                                           
        no par value; 55,000,000 shares authorized, 36,761,362 and 36,534,464 issued and outstanding at december 31, 2017 and 2016, respectively
                                      265,048,000                                                           
        no par value; 55,000,000 shares authorized, 36,677,528 and 36,534,464 issued and outstanding at september 30, 2017 and december 31, 2016, respectively
                                       262,935,000                                                          
        no par value; 55,000,000 shares authorized, 36,821,656 and 36,534,464 issued and outstanding at june 30, 2017 and december 31, 2016, respectively
                                        266,077,000                                                         
        no par value; 55,000,000 shares authorized, 36,727,501 and 36,534,464 issued and outstanding at march 31, 2017 and december 31, 2016, respectively
                                         263,656,000                                                        
        other intangible assets, net of accumulated amortization of 53,965 and 59,594, respectively
                                          57,557,000                                                       
        no par value; 55,000,000 shares authorized, 36,534,464 and 36,321,775 issued and outstanding at december 31, 2016 and 2015, respectively
                                          262,251,000                                                       
        no par value; 55,000,000 shares authorized, 36,495,338 and 36,321,775 issued and outstanding at september 30, 2016 and december 31, 2015, respectively
                                           260,598,000                                                      
        no par value; 55,000,000 shares authorized, 36,469,431 and 36,321,775 issued and outstanding at june 30, 2016 and december 31, 2015, respectively
                                            259,309,000                                                     
        no par value; 55,000,000 shares authorized, 36,407,397 and 36,321,775 issued and outstanding at march 31, 2016 and december 31, 2015, respectively
                                             257,401,000                                                    
        other intangible assets, net of accumulated amortization of 59,594 and 53,756, respectively
                                              48,461,000                                                   
        no par value; 55,000,000 shares authorized, 36,321,775 and 35,696,742 issued and outstanding at december 31, 2015 and 2014, respectively
                                              256,919,000                                                   
        no par value; 55,000,000 shares authorized, 36,210,905 and 35,696,334 issued and outstanding at september 30, 2015 and december 31, 2014, respectively
                                               252,621,000                                                  
        no par value; 55,000,000 shares authorized, 36,055,652 and 35,696,334 issued and outstanding at june 30, 2015 and december 31, 2014, respectively
                                                249,661,000                                                 
        no par value; 55,000,000 shares authorized, 35,890,326 and 35,696,334 issued and outstanding at march 31, 2015 and december 31, 2014, respectively
                                                 246,133,000                                                
        cash & cash equivalents
                                                  85,700,000  43,154,000 57,651,000 54,885,000 36,003,000 49,401,000 47,977,000 58,152,000 72,279,000 77,294,000 100,601,000 23,839,000 17,062,000 27,635,000 6,584,000 26,584,000 25,235,000 20,449,000 18,513,000 21,677,000 24,904,000 26,167,000 25,185,000 25,303,000 15,209,000 13,609,000 2,563,000 1,170,000 2,237,000 2,911,000 2,440,000 1,219,000 1,956,000 1,364,000 1,379,000 1,547,000 8,400,000 7,603,000 844,000 44,000 454,000 336,000 274,000 602,000 1,340,000 4,209,000 
        other intangible assets, net of accumulated amortization of 53,756 and 44,474, respectively
                                                  68,129,000                                               
        no par value; 55,000,000 shares authorized, 35,696,742 and 34,929,334 issued and outstanding at december 31, 2014 and 2013, respectively
                                                  243,255,000                                               
        no par value; 55,000,000 shares authorized, 35,641,556 and 34,929,334 issued and outstanding at september 30, 2014 and december 31, 2013, respectively
                                                   242,549,000                                              
        no par value; 55,000,000 shares authorized, 35,451,435 and 34,929,334 issued and outstanding at june 30, 2014 and december 31, 2013, respectively
                                                    238,091,000                                             
        no par value; 55,000,000 shares authorized, 35,260,144 and 34,929,334 issued and outstanding at march 31, 2014 and december 31, 2013, respectively
                                                     234,991,000                                            
        other intangible assets, net of accumulated amortization of 44,474 and 28,575, respectively
                                                      83,431,000                                           
        commitments and contingencies
                                                                                                 
        series c convertible preferred stock
                                                        6,809,000 13,527,000 22,469,000 29,633,000 36,631,000 43,450,000 50,098,000 56,589,000 62,931,000 61,465,000                                
        no par value; 55,000,000 shares authorized, 34,929,334 and 29,818,225 issued and outstanding at december 31, 2013 and 2012, respectively
                                                      232,067,000                                           
        total gentherm incorporated shareholders’ equity
                                                      232,094,000 214,455,000 190,713,000 177,583,000 161,815,000 161,311,000                                      
        non-controlling interest
                                                       1,191,000 1,138,000 2,665,000 53,348,000 50,669,000 48,072,000 46,786,000 44,194,000 45,380,000 46,485,000   -865,000 -736,000 -546,000 -439,000 -342,000                          
        no par value; 55,000,000 shares authorized, 34,689,569 and 29,818,225 issued and outstanding at september 30, 2013 and december 31, 2012, respectively
                                                       228,985,000                                          
        no par value; 55,000,000 shares authorized, 34,052,503 and 29,818,225 issued and outstanding at june 30, 2013 and december 31, 2012, respectively
                                                        221,079,000                                         
        accumulated deficit
                                                        -4,686,000 -9,655,000 -17,383,000 -16,685,000 -19,267,000 -23,003,000 -25,716,000 -31,899,000 -30,080,000 -28,498,000 -27,832,000 -31,134,000 -33,825,000 -36,132,000 -37,782,000 -39,179,000 -40,310,000 -39,441,000 -38,505,000 -38,796,000 -39,444,000 -40,698,000 -42,069,000 -46,894,000 -48,150,000 -49,444,000 -50,474,000 -52,190,000 -52,958,000 -67,713,000 -68,591,000 -69,045,000 -69,507,000 -70,566,000 -70,831,000 -70,685,000 -70,076,000 -69,151,000 -68,010,000 -66,599,000 -64,944,000 
        no par value; 55,000,000 shares authorized, 33,425,765 and 29,818,225 issued and outstanding at march 31, 2013 and december 31, 2012, respectively
                                                         212,867,000                                        
        other intangible assets, net of accumulated amortization of 28,575 and 14,137, respectively
                                                          95,870,000                                       
        no par value; 55,000,000 shares authorized, 29,818,225 and 23,515,571 issued and outstanding at december 31, 2012 and 2011, respectively
                                                          166,309,000                                       
        no par value; 55,000,000 shares authorized, 29,701,225 and 23,515,571 issued and outstanding at september 30, 2012 and december 31, 2011, respectively
                                                           166,126,000                                      
        no par value; 55,000,000 shares authorized, 29,584,041 and 23,515,571 issued and outstanding at june 30, 2012 and december 31, 2011, respectively
                                                            165,498,000                                     
        total amerigon incorporated shareholders’ equity
                                                            154,363,000 155,350,000 63,521,000 65,271,000 62,480,000  57,537,000                               
        no par value; 55,000,000 shares authorized, 29,548,163 and 23,515,571 issued and outstanding at march 31, 2012 and december 31, 2011, respectively
                                                             165,401,000                                    
        short-term investments
                                                                  9,761,000 10,212,000 9,589,000 10,596,000 6,704,000     11,500,000  1,150,000 23,925,000 16,162,000 15,525,000 12,076,000 9,050,000 9,075,000 9,975,000 8,325,000 8,425,000           
        other intangible assets, net of accumulated amortization of 14,388 and 706, respectively
                                                              108,481,000                                   
        other liabilties
                                                              1,862,000                                   
        no par value; 55,000,000 shares authorized, 23,515,571 and 22,037,446 issued and outstanding at december 31, 2011 and 2010, respectively
                                                              80,502,000                                   
        deferred manufacturing agreement – current portion
                                                                   100,000 150,000 200,000  200,000 200,000 200,000  200,000 200,000 200,000  200,000 200,000  200,000 200,000  200,000 200,000 200,000   200,000 200,000 200,000  200,000   
        no par value; 55,000,000 shares authorized, 23,170,154 and 22,037,466 issued and outstanding at september 30, 2011 and december 31, 2010, respectively
                                                               77,459,000                                  
        no par value; 55,000,000 shares authorized, 22,241,030 and 22,037,446 issued and outstanding at june 30, 2011 and december 31, 2010, respectively
                                                                66,998,000                                 
        patent costs, net of accumulated amortization of 761 and 706, respectively
                                                                 5,019,000                                
        debt
                                                                 87,233,000                                
        no par value; 30,000,000 shares authorized, 22,150,780 and 22,037,446 issued and outstanding at march 31, 2011 and december 31, 2010, respectively
                                                                 66,009,000                                
        equity investment
                                                                      22,000 385,000                          
        patent costs, net of accumulated amortization of 706 and 490, respectively
                                                                  4,653,000                               
        deferred manufacturing agreement—current portion
                                                                  50,000    200,000    200,000    200,000   200,000   200,000    200,000 200,000    200,000  200,000 200,000 
        deferred manufacturing agreement—long term portion
                                                                      50,000    250,000    450,000   650,000   850,000    1,050,000 1,250,000    1,450,000  1,550,000 1,600,000 
        no par value; 30,000,000 shares authorized, 22,037,446 and 21,486,309 issued and outstanding at december 31, 2010 and 2009, respectively
                                                                  65,148,000                               
        patent costs, net of accumulated amortization of 651 and 490, respectively
                                                                   4,465,000                              
        deferred manufacturing agreement – long-term portion
                                                                       100,000 150,000 200,000  300,000 350,000 400,000  550,000 600,000                 
        no par value; 30,000,000 shares authorized, 21,805,247 and 21,486,309 issued and outstanding at september 30, 2010 and december 31, 2009, respectively
                                                                   63,589,000                              
        total amerigon, inc. shareholders’ equity
                                                                   57,194,000 53,343,000 50,632,000 48,234,000 46,446,000                          
        patent costs, net of accumulated amortization of 640 and 490, respectively
                                                                    4,319,000                             
        no par value; 30,000,000 shares authorized, 21,635,807 and 21,486,309 issued and outstanding at june 30, 2010 and december 31, 2009, respectively
                                                                    62,537,000                             
        patent costs, net of accumulated amortization of 508 and 490, respectively
                                                                     4,121,000                            
        no par value; 30,000,000 shares authorized, 21,608,307 and 21,486,309 issued and outstanding at march 31, 2010 and december 31, 2009, respectively
                                                                     62,491,000                            
        patent costs, net of accumulated amortization of 490 and 298, respectively
                                                                      3,727,000                           
        no par value; 30,000,000 shares authorized, 21,486,309 and 21,205,492 issued and outstanding at december 31, 2009 and 2008, respectively
                                                                      61,971,000                           
        patent costs, net of accumulated amortization of 440 and 298, respectively
                                                                       3,634,000                          
        no par value; 30,000,000 shares authorized, 21,472,492 and 21,205,492 issued and outstanding at september 30, 2009 and december 31, 2008, respectively
                                                                       61,872,000                          
        accumulated other comprehensive income – foreign currency
                                                                       101,000 69,000 58,000  -6,000 -8,000 -5,000  -23,000 -6,000  -14,000 -19,000              
        patent costs, net of accumulated amortization of 392 and 298, respectively
                                                                        3,522,000                         
        no par value; 30,000,000 shares authorized, 21,467,492 and 21,205,492 issued and outstanding at june 30, 2009 and december 31, 2008, respectively
                                                                        61,822,000                         
        patent costs, net of accumulated amortization of 345 and 298, respectively
                                                                         3,300,000                        
        revolving credit line
                                                                         1,300,000                        
        no par value; 30,000,000 shares authorized, 21,378,492 and 21,205,492 issued and outstanding at march 31, 2009 and december 31, 2008, respectively
                                                                         61,529,000                        
        patent costs, net of accumulated amortization of 298 and 121, respectively
                                                                          3,156,000                       
        no par value; 30,000,000 shares authorized, 21,205,492 and 21,917,733 issued and outstanding at december 31, 2008 and 2007, respectively
                                                                          60,727,000                       
        accumulated other comprehensive income—foreign currency
                                                                          97,000    -16,000   -12,000                
        patent costs, net of accumulated amortization of 251 and 121, respectively
                                                                           3,054,000                      
        no par value; 30,000,000 shares authorized, 22,152,369 and 21,917,733 issued and outstanding at september 30, 2008 and december 31, 2007, respectively
                                                                           64,022,000                      
        long-term investments
                                                                            13,025,000 22,025,000     659,000               
        patent costs, net of accumulated amortization of 208 and 121, respectively
                                                                            2,853,000                     
        no par value; 30,000,000 shares authorized, 22,150,369 and 21,917,733 issued and outstanding at june 30, 2008 and december 31, 2007, respectively
                                                                            63,968,000                     
        patent costs, net of accumulated amortization of 164 and 121, respectively
                                                                             2,789,000                    
        no par value; 30,000,000 shares authorized, 22,127,035 and 21,917,733 issued and outstanding at march 31, 2008 and december 31, 2007, respectively
                                                                             63,847,000                    
        patent costs, net of accumulated amortization of 121 and 28, respectively
                                                                              2,679,000                   
        no par value; 30,000,000 shares authorized, 21,917,733 and 21,335,188 issued and outstanding at december 31, 2007 and 2006, respectively
                                                                              63,028,000                   
        patent costs, net of accumulated amortization of 21 and 18, respectively
                                                                               2,508,000                  
        no par value; 30,000,000 shares authorized, 21,654,383 and 21,335,188 issued and outstanding at june 30, 2007 and december 31, 2006, respectively
                                                                               62,231,000                  
        patent costs, net of accumulated amortization of 20 and 18, respectively
                                                                                923,000                 
        no par value; 30,000,000 shares authorized, 21,611,866 and 21,335,188 issued and outstanding at march 31, 2007 and december 31, 2006, respectively
                                                                                62,085,000                 
        patent costs, net of accumulated amortization of 18 and 11, respectively
                                                                                 835,000                
        convertible preferred stock:
                                                                                                 
        series a—no par value; convertible; 9,000 shares authorized, no shares issued and outstanding at december 31, 2006 and 9,000 shares issued and outstanding at december 31, 2005; liquidation preference of 11,520 at december 31, 2005
                                                                                                 
        no par value; 30,000,000 shares authorized, 21,335,188 and 15,874,557 issued and outstanding at december 31, 2006 and 2005, respectively
                                                                                 61,606,000                
        patent costs, net of accumulated amortization of 15 and 11, respectively
                                                                                  784,000               
        deferred manufacturing agreement – long term portion
                                                                                  700,000 800,000  900,000 950,000 1,000,000   1,300,000 1,350,000 1,400,000  1,500,000   
        series a – no par value; convertible; 9,000 shares authorized, no shares issued and outstanding on september 30, 2006 and 9,000 shares issued and outstanding at december 31, 2005 liquidation preference of 11,520 at december 31, 2005
                                                                                                 
        no par value; 30,000,000 shares authorized, 21,324,541 and 15,874,557 issued and outstanding at september 30, 2006 and december 31, 2005, respectively
                                                                                  61,572,000               
        patent costs, net of accumulated amortization of 12 and 11, respectively
                                                                                   588,000              
        series a – no par value; convertible; 9,000 shares authorized, 4,500 and 9,000 issued and outstanding at march 31, 2006 and december 31, 2005, respectively; liquidation preference of 5,760 and 11,520 at march 31, 2006 and december 31, 2005, respectively
                                                                                   4,134,000              
        no par value; 30,000,000 shares authorized, 18,562,975 and 15,874,557 issued and outstanding at march 31, 2006 and december 31, 2005, respectively
                                                                                   57,279,000              
        patent costs, net of accumulated amortization of 11 and 4, respectively
                                                                                    533,000             
        series a—no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at december 31, 2005 and 2004; liquidation preference of 11,520 at december 31, 2005 and 2004
                                                                                    8,267,000             
        no par value; 30,000,000 shares authorized, 15,874,557 and 14,693,251 issued and outstanding at december 31, 2005 and 2004, respectively
                                                                                    53,142,000             
        total inventory
                                                                                     2,214,000 1,731,000 1,647,000          
        patent costs, net of accumulated amortization of 5 and 4, respectively
                                                                                     486,000            
        preferred stock:
                                                                                                 
        series a – no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at september 30, 2005 and december 31, 2004; liquidation preference of 11,520 september 30, 2005 and december 31, 2004
                                                                                     8,267,000            
        no par value; 30,000,000 shares authorized, 15,852,107 and 14,693,251 issued and outstanding at september 30, 2005 and december 31, 2004, respectively
                                                                                     53,084,000            
        patent costs, net of accumulated amortization of 4 and 4, respectively
                                                                                      492,000 379,000 333,000         
        series a – no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at june 30, 2005 and december 31, 2004; liquidation preference of 11,520 june 30, 2005 and december 31, 2004
                                                                                      8,267,000           
        no par value; 30,000,000 shares authorized, 15,516,020 and 14,693,251 issued and outstanding at june 30, 2005 and december 31, 2004, respectively
                                                                                      52,697,000           
        series a – no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at march 31, 2005 and december 31, 2004; liquidation preference of 11,520 at march 31, 2005 and december 31, 2004
                                                                                       8,267,000          
        no par value; 30,000,000 shares authorized, 15,516,020 and 14,693,251 issued and outstanding at march 31, 2005 and december 31, 2004, respectively
                                                                                       52,706,000          
        deferred exclusivity fee
                                                                                         293,000 366,000 439,000 512,000 585,000 658,000 731,000 805,000 
        minority interest in subsidiary
                                                                                         19,000    2,000  5,000 33,000 
        series a—no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at december 31, 2004 and 2003; liquidation preference of 11,520 at december 31, 2004 and 2003
                                                                                        8,267,000         
        no par value; 30,000,000 shares authorized, 14,693,251 and 12,411,000 issued and outstanding at december 31, 2004 and 2003, respectively
                                                                                        51,277,000         
        patent costs, net of accumulated amortization of 4 and nil, respectively
                                                                                         193,000        
        bank loan payable
                                                                                          526,000 391,000 1,564,000 670,000    
        series a—no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at december 31, 2003 and 2002; liquidation preference of 11,520 at december 31, 2003 and 11,205 at december 31, 2002
                                                                                         8,267,000        
        common stock;
                                                                                                 
        no par value; 30,000,000 shares authorized, 12,411,000 and 10,771,000 issued and outstanding at december 31, 2003 and 2002
                                                                                         46,758,000        
        series a – no par value; convertible; 9,000 shares authorized, 9000 issued and outstanding at september 30, 2003 and december 31, 2002; liquidation preference of 11,678 and 11,205 at september 30, 2003 and december 31, 2002
                                                                                          8,267,000       
        no par value; 30,000,000 shares authorized, 12,136,956 and 10,771,230 issued and outstanding at september 30, 2003 and december 31, 2002
                                                                                          46,212,000       
        series a – no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at june 30, 2003 and december 31, 2002; liquidation preference of 11,520 and 11,205 at june 30, 2003 and december 31, 2002.
                                                                                           8,267,000      
        no par value; 30,000,000 shares authorized, 12,021,230 and10,771,230 issued and outstanding at june 30, 2003 and december 31, 2002.
                                                                                           45,999,000      
        accounts receivable less allowance of 59 and 55, respectively
                                                                                            3,588,000     
        series a – no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at march 31, 2003 and december 31, 2002; liquidation preference of 11,363 and 11,205 at march 31, 2003 and december 31, 2002
                                                                                            8,267,000     
        no par value; 30,000,000 shares authorized, 10,771,000 issued and outstanding at march 31, 2003 and december 31, 2002
                                                                                            43,051,000     
        bridge loan payable
                                                                                              501,000   
        shareholders’ equity
                                                                                                 
        series a—no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at december 31, 2002 and 2001; liquidation preference of 11,205 at december 31, 2002
                                                                                             8,267,000    
        no par value; 30,000,000 shares authorized, 10,771,000 and 4,717,000 issued and outstanding at december 31, 2002 and 2001
                                                                                             43,051,000    
        deferred compensation
                                                                                              -22,000 -22,000 -22,000 
        series a—no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at june 30, 2002 and december 31, 2001; liquidation preference of 10,890 at june 30, 2002
                                                                                               8,267,000  
        no par value; 30,000,000 shares authorized, 10,771,000 and 4,717,000 issued and outstanding at june 30, 2002 and december 31, 2001
                                                                                               43,051,000  
        accounts receivable less allowance of 50
                                                                                                1,175,000 
        series a—no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at march 31, 2002 and december 31, 2001; liquidation preference of 10,733 and 10,575 at march 31, 2002 and december 31, 2001
                                                                                                8,267,000 
        no par value; 20,000,000 shares authorized, 10,771,000 and 4,717,000 issued and outstanding at march 31, 2002 and december 31, 2001
                                                                                                43,077,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 
                                                                                                    
          operating activities:
                                                                                                    
          net income
        2,987,000 14,949,000 477,000 -128,000 15,321,000 15,965,000 18,876,000 14,785,000 18,087,000 15,844,000 -1,551,000 7,963,000 -4,205,000 9,827,000 7,072,000 11,747,000 20,048,000 15,686,000 24,791,000 32,909,000 33,993,000 24,146,000 -10,322,000 11,873,000 10,454,000 15,887,000 2,751,000 8,414,000 12,629,000 -355,000 16,659,000 12,966,000 -5,242,000 6,554,000 8,513,000 25,402,000 26,036,000 20,223,000 18,446,000 11,893,000 28,414,000 27,665,000 19,494,000 19,820,000 19,829,000 17,288,000 16,423,000 16,579,000 10,931,000 8,765,000 5,528,000 9,909,000 5,278,000 5,770,000 7,008,000 6,265,000 10,218,000 1,519,000 818,000 -666,000 3,136,000 2,562,000 2,117,000 1,543,000 1,300,000 789,000 -869,000 -936,000 291,000 648,000 1,254,000 1,371,000 1,769,000 3,056,000 1,256,000 1,294,000 1,030,000 900,000 816,000 768,000 14,755,000 878,000 454,000 462,000         
          adjustments to reconcile net income to net cash from operating activities:
                                                                                                    
          depreciation and amortization
        13,901,000 13,389,000 13,158,000 12,931,000 12,890,000 13,352,000 12,915,000 13,818,000 12,417,000 12,454,000 12,494,000 13,583,000 13,924,000 11,835,000 9,058,000 9,577,000 9,350,000 9,859,000 9,717,000 9,854,000 10,337,000 10,289,000 10,082,000 10,406,000 10,965,000 11,064,000 11,165,000 11,052,000 11,917,000 12,898,000 12,931,000 12,892,000 12,309,000 11,472,000 10,999,000 10,192,000 10,040,000 10,177,000 9,383,000 8,164,000 7,906,000 7,800,000 7,864,000 7,459,000 10,464,000 8,634,000 8,458,000 7,473,000 7,782,000 7,737,000 7,796,000 7,934,000 7,725,000 7,500,000 7,826,000 7,576,000 7,898,000 9,360,000 5,704,000 390,000 354,000 339,000 353,000 322,000 289,000 445,000 334,000 370,000 393,000 355,000 318,000 307,000 221,000 177,000 137,000 119,000 118,000 138,000 157,000 76,000 102,000 127,000 122,000 89,000  142,000 121,000 125,000 186,000 127,000 138,000 121,000 
          deferred income taxes
        -9,500,000 -634,000 -9,433,000 -2,769,000 9,012,000 -2,797,000 4,549,000 -184,000 -10,055,000 -205,000 -1,026,000 -1,786,000 -6,115,000 -210,000 -219,000 -778,000 -4,017,000 4,092,000 -330,000 105,000 -2,734,000 4,496,000 -1,634,000 721,000 -1,455,000 2,002,000 1,321,000 1,749,000 6,718,000 1,780,000 -1,092,000 -707,000 14,194,000 -6,781,000 -2,954,000 676,000                                                         
          stock based compensation
        1,727,000 3,969,000 3,983,000 2,621,000 141,000 2,899,000 3,603,000 3,789,000 3,176,000 3,398,000 3,030,000 2,023,000           1,967,000 1,942,000                                                                     
          provisions for inventory
        1,581,000 2,021,000 1,786,000 1,427,000 5,935,000 -291,000 497,000 296,000 270,000 4,667,000 226,000 1,704,000                                                                                 
          loss on disposition of property and equipment
        354,000 227,000 106,000 2,338,000 99,000 -1,660,000 -111,000 69,000 -152,000 45,000 812,000 16,000 151,000 102,000 411,000 107,000 335,000 142,000                                                                           
          impairment of intangible assets and property and equipment
                                                                                                    
          impairment of goodwill
                                                                                                  
          other non-cash items, including unrealized foreign currency loss
        3,771,000 -407,000                                                                                           
          changes in assets and liabilities:
                                                                                                    
          accounts receivable
        11,243,000 3,147,000 -1,093,000 -22,597,000 4,102,000 -1,869,000 546,000 -14,856,000 15,618,000 -8,189,000 -3,387,000 -8,237,000 11,559,000 -24,018,000 -5,974,000 -25,788,000 -1,063,000 14,515,000 25,578,000 -13,931,000 -13,492,000 -71,055,000 40,296,000 -2,491,000 12,971,000 -2,149,000 4,272,000 -8,293,000 16,879,000 3,614,000 -7,778,000 -9,691,000 11,614,000 1,368,000 6,951,000 -13,900,000 4,864,000 -10,167,000 9,238,000 -21,906,000 12,043,000 -7,731,000 -717,000 -15,994,000 8,288,000 -7,734,000 3,697,000 -21,153,000 5,778,000 -7,578,000 -4,263,000 -7,765,000 -1,639,000 -5,480,000 -5,667,000 -5,581,000 4,562,000 -14,348,000 3,869,000 -6,722,000 4,316,000 -2,593,000 -3,304,000 -3,034,000 -313,000 -7,926,000 1,870,000 -385,000 3,278,000 -64,000 1,483,000 -1,094,000 715,000 -1,748,000 397,000 -2,022,000 2,653,000 -1,783,000 -2,287,000 47,000 -950,000 -1,919,000 1,809,000 -2,297,000 1,227,000 -3,263,000 -259,000 942,000 -1,610,000 -789,000 -960,000 93,000 
          inventory
        -1,493,000 -6,706,000 -7,289,000 -6,141,000 -6,369,000 -15,488,000 4,310,000 -16,648,000 3,174,000 -5,684,000 10,554,000 -1,137,000 8,608,000 -15,293,000 -15,521,000 -18,116,000 -5,854,000 -16,808,000 -5,665,000 -11,546,000 -5,459,000 -647,000 5,696,000 -404,000 1,653,000 -7,162,000 1,879,000 -229,000 -4,179,000 -5,141,000 -272,000 1,903,000 59,000 -5,556,000 3,556,000 -2,407,000 -286,000 -12,271,000 7,847,000 -1,223,000 -7,125,000 604,000 1,329,000 -5,762,000 -4,367,000 -9,024,000 4,567,000 457,000 -776,000 -5,989,000 -3,262,000 427,000 -1,597,000 -4,819,000 3,067,000 -2,498,000 1,280,000 -7,162,000 1,758,000 -500,000 -3,436,000 -483,000 216,000 -582,000 -403,000 1,339,000 -79,000 -757,000 1,803,000 393,000 -1,666,000 -951,000 -815,000 303,000 197,000 2,465,000 567,000 -1,804,000 -61,000 -358,000 -498,000 -483,000 -84,000 253,000 248,000 613,000 -1,062,000 -394,000 20,000 712,000 -605,000 -867,000 
          other assets
        4,545,000 777,000 4,210,000 -27,312,000 -8,737,000 915,000 -7,648,000 -29,226,000 -6,961,000 -6,977,000 -5,824,000 -6,417,000 -1,038,000 -425,000 273,000 -10,716,000 10,297,000 -3,976,000 3,431,000 555,000 -13,585,000 -7,543,000 7,693,000 -4,805,000                                                                     
          accounts payable
        -5,951,000 12,992,000 6,186,000 14,336,000 -22,279,000 30,065,000 -3,901,000 12,337,000 -1,129,000 7,640,000 229,000 24,289,000 -32,669,000 33,215,000 -6,329,000 34,097,000 -1,065,000 9,520,000 -18,402,000 18,113,000 5,688,000 42,025,000 -31,293,000 13,540,000 -7,156,000 6,431,000 -7,449,000 -2,079,000 4,004,000 -2,164,000 9,250,000 1,290,000 -258,000 -4,501,000 -4,026,000 1,094,000 -2,089,000 4,759,000 -4,643,000 6,392,000 6,327,000 -11,426,000 -2,374,000 15,522,000 -1,083,000 9,351,000 -4,110,000 2,798,000 7,005,000 -3,220,000 14,630,000 -160,000 -2,834,000 4,668,000 -627,000 581,000 -4,908,000 11,426,000 -5,858,000 4,062,000 -1,436,000 3,839,000 371,000 2,279,000 912,000 3,929,000 1,023,000 485,000 -2,816,000 -1,550,000 -1,560,000 1,159,000 476,000 1,953,000 -74,000 670,000 -2,014,000 1,775,000 927,000 -396,000 1,456,000 338,000 -686,000 1,015,000 -1,199,000 1,478,000 305,000 -622,000 1,928,000 94,000 523,000 305,000 
          other liabilities
        5,806,000 12,395,000 2,672,000 10,868,000 24,040,000 5,368,000 3,531,000 6,340,000 1,939,000 -1,903,000 -1,348,000 -6,848,000 -13,495,000 3,317,000 4,791,000 -3,349,000 -7,548,000 1,101,000 -1,472,000 18,579,000 17,574,000 -1,549,000 -3,669,000                                                                     
          net cash from operating activities
        28,971,000 56,119,000 45,045,000 -13,344,000 36,557,000 46,265,000 37,146,000 -10,322,000 39,223,000 21,430,000 33,503,000 25,109,000 1,990,000 16,643,000 -3,002,000 -684,000 25,970,000 32,744,000 44,695,000 39,667,000 37,394,000 23,074,000 20,808,000 29,419,000 34,811,000 43,584,000 33,527,000 6,881,000 47,893,000 37,998,000 26,953,000 5,590,000 34,509,000 9,256,000 27,451,000 -21,336,000 37,389,000 19,838,000 44,825,000 6,348,000 38,376,000 26,564,000 30,943,000 8,829,000 34,884,000 21,085,000 27,522,000 -3,156,000 31,177,000 2,182,000 16,396,000 10,039,000 7,492,000 11,766,000 10,819,000 6,788,000 28,735,000 130,000 4,442,000 2,063,000 3,717,000 5,101,000 1,232,000 2,344,000 3,991,000 -662,000 2,442,000 -1,518,000 2,435,000 1,010,000 1,261,000 839,000 4,863,000 3,106,000 2,866,000 3,402,000 3,998,000 826,000 -171,000 165,000 1,878,000 -625,000 1,793,000 -526,000 941,000 -725,000 -1,478,000 -605,000 -665,000 -1,186,000 -2,809,000 -2,282,000 
          capital expenditures
        -22,295,000 -9,650,000 -8,857,000 -14,871,000 -22,960,000 -19,650,000 -19,384,000 -11,320,000 -11,076,000 -12,859,000 -7,373,000 -6,294,000 -13,966,000 -10,289,000 -9,789,000 -5,659,000 -8,883,000 -8,916,000 -10,756,000 -9,913,000 -5,606,000 -4,113,000 -4,269,000 -3,231,000 -5,389,000 -5,316,000 -7,874,000 -5,150,000 -9,726,000 -9,677,000 -13,760,000 -8,378,000 -13,604,000 -11,431,000 -12,188,000 -13,562,000 -15,574,000 -19,914,000 -13,818,000 -17,010,000 -19,762,000 -12,699,000 -12,626,000 -10,403,000 -11,501,000 -8,720,000 -6,769,000 -11,984,000 -11,916,000 -6,116,000 -11,449,000 -7,218,000 -5,097,000 -3,029,000 -6,812,000 -577,000 -2,551,000 -696,000 -404,000 -55,000 -126,000 -372,000 -324,000 -51,000 -171,000 -198,000 -107,000 -358,000 -373,000 -874,000 -681,000 -1,135,000 -841,000 -94,000 -389,000 -372,000 -356,000 -401,000 -234,000 -34,000 -99,000 -60,000 -34,000 -181,000 -225,000 -23,000 -290,000 -189,000 -169,000 
          free cash flows
        6,676,000 46,469,000 36,188,000 -28,215,000 13,597,000 26,615,000 17,762,000 -21,642,000 28,147,000 8,571,000 26,130,000 18,815,000 -11,976,000 6,354,000 -12,791,000 -6,343,000 17,087,000 23,828,000 33,939,000 29,754,000 31,788,000 18,961,000 16,539,000 26,188,000 29,422,000 38,268,000 25,653,000 1,731,000 38,167,000 28,321,000 13,193,000 -2,788,000 20,905,000 -2,175,000 15,263,000 -34,898,000 21,815,000 -76,000 31,007,000 -10,662,000 18,614,000 13,865,000 18,317,000 -1,574,000 34,884,000 9,584,000 18,802,000 -9,925,000 31,177,000 -9,802,000 4,480,000 3,923,000 -3,957,000 4,548,000 5,722,000 3,759,000 21,923,000 -447,000 1,891,000 1,367,000 3,313,000 5,046,000 1,106,000 1,972,000 3,667,000 -713,000 2,271,000 -1,716,000 2,328,000 652,000 888,000 -35,000 4,182,000 1,971,000 2,025,000 3,308,000 3,609,000 454,000 -527,000 -236,000 1,644,000 -659,000 1,694,000 -586,000 941,000 -759,000 -1,659,000 -830,000 -688,000 -1,476,000 -2,998,000 -2,451,000 
          investing activities:
                                                                                                    
          purchases of property and equipment
        -22,295,000 -9,650,000 -8,857,000 -14,871,000 -22,960,000 -19,650,000 -19,384,000 -11,320,000 -11,076,000 -12,859,000 -7,373,000 -6,294,000 -13,966,000 -10,289,000 -9,789,000 -5,659,000 -8,883,000 -8,916,000 -10,756,000 -9,913,000 -5,606,000 -4,113,000 -4,269,000 -3,231,000 -5,389,000 -5,316,000 -7,874,000 -5,150,000 -9,726,000 -9,677,000 -13,760,000 -8,378,000 -13,604,000 -11,431,000 -12,188,000 -13,562,000 -15,574,000 -19,914,000 -13,818,000 -17,010,000 -19,762,000 -12,699,000 -12,626,000 -10,403,000                                                 
          proceeds from the sale of property and equipment
        25,000 2,000 3,743,000 325,000 7,456,000 59,000 22,000 319,000 32,000 23,000 17,000  94,000 29,000 52,000    10,000    34,000 82,000 55,000 54,000 28,000 96,000 5,000   50,000 7,000 24,000 10,000 12,000 18,000 9,000 18,000 22,000 1,000 44,000 181,000 391,000                                                
          proceeds from deferred purchase price of factored receivables
        1,000 744,000 2,610,000 4,058,000 3,476,000 2,732,000 3,764,000 2,788,000 3,623,000 3,728,000 3,370,000                                                                                
          cost of technology investments
        -325,000 -325,000 -440,000 -150,000 -365,000 -325,000 -265,000 -185,000 -130,000   -145,000 -350,000                                                                            
          net cash from investing activities
        -22,619,000 -9,950,000 -9,295,000 -10,534,000 -20,390,000 -8,461,000 -15,849,000 -8,831,000 -7,178,000 -10,169,000 -4,227,000 -2,549,000 7,942,000 -232,124,000 -9,760,000 -5,957,000 -8,872,000 -14,099,000 -15,756,000 -10,103,000 -4,534,000 -4,106,000 -3,242,000 -6,338,000 -8,634,000 -4,608,000 -23,296,000 42,378,000 -9,630,000 -9,672,000 -13,062,000 -8,393,000 -78,548,000 -11,424,000 -12,164,000 -15,552,000 -20,048,000 -19,823,000 -87,475,000 -16,992,000 -27,179,000 -12,698,000 -12,582,000 -10,269,000 -11,241,000 -11,449,000 -39,831,000 -7,353,000 -7,573,000 -12,260,000 -18,433,000 -46,417,000 -8,836,000 -9,640,000 -13,045,000 -3,874,000 -8,688,000 -309,000 65,947,000 -174,054,000 -3,578,000 -1,145,000 628,000 -5,926,000 -7,236,000 -653,000 -439,000 -389,000 11,053,000 923,000 9,669,000 -277,000 -6,079,000 -3,761,000 -3,064,000 -3,632,000 -2,811,000 -1,801,000 243,000 442,000 -1,936,000 71,000 -2,112,000 -106,000 -161,000 -34,000 -178,000 -227,000 -398,000 -53,000 -34,000 -187,000 
          financing activities:
                                                                                                    
          borrowings on debt
        40,000,000 20,000,000 52,000,000 15,000,000 18,000,000 25,000,000 10,000,000                                                                                    
          repayments of debt
        -40,037,000 -40,036,000 -53,039,000 -10,037,000 -17,095,000 -18,100,000 -25,096,000 -10,324,000 -45,114,000 -10,184,000 -16,418,000 -564,000 -1,713,000 -10,309,000   -1,250,000 -8,262,000 -13,731,000 -130,000,000 -3,751,000 -5,858,000 -65,719,000 -16,111,000 -27,950,000 -7,929,000 -11,493,000 -49,627,000 -38,250,000 -14,468,000 -11,250,000 -35,492,000 -1,250,000 -17,478,000 -1,000 -8,427,000 -9,876,000 -450,000 -31,472,000 -446,000 -897,000 -1,355,000 -1,132,000 -1,669,000 -2,788,000 -64,434,000 -5,505,000 -6,965,000 -5,530,000 -8,680,000 -5,104,000 -5,182,000 -3,804,000 -3,746,000 -11,790,000 -3,613,000 -4,875,000 -7,041,000                                   
          proceeds from the exercise of common stock options
            1,141,000 1,887,000 1,951,000 812,000 263,000 114,000 987,000 569,000 812,000 1,175,000 308,000 5,984,000 9,724,000 650,000 276,000 5,902,000 2,678,000 9,108,000 4,557,000 214,000 715,000 9,096,000 4,215,000 751,000 321,000 373,000 1,180,000 881,000 400,000 472,000 362,000 204,000 2,805,000 2,346,000 2,096,000 2,026,000 894,000 2,876,000 1,772,000 1,634,000 1,900,000 490,000 924,000 1,487,000 41,000 393,000 69,000 271,000 2,087,000 331,000 295,000 632,000  789,000 46,000 421,000  20,000 267,000 529,000  -336,000 120,000 820,000  165,000 146,000 90,000                 
          taxes withheld and paid on employees' share-based payment awards
               -2,022,000 -186,000 -110,000 23,000 -2,667,000 -56,000 -951,000 -145,000 -4,319,000                                                                             
          cash paid for the repurchase of common stock
          -10,007,000 -19,875,000   -60,000,000 -11,101,000 -9,996,000 -9,997,000         -9,092,000         -5,273,000                                                           
          net cash from financing activities
        -50,000 -20,104,000 -63,068,000 40,739,000 -11,100,000 -18,828,000 -20,243,000 -1,534,000 -45,300,000 -21,395,000 -26,391,000 -12,965,000  196,727,000 -1,395,000 -3,750,000 -20,555,000 -8,961,000 -14,009,000 -125,616,000 5,668,000 -6,166,000 -33,863,000 149,841,000 -22,362,000 -23,009,000 -15,821,000 -47,401,000 -45,085,000 -46,282,000 -12,499,000 -35,400,000 -1,666,000 -22,378,000 952,000 -8,472,000 38,311,000 -273,000 -31,110,000 72,930,000 7,369,000 14,741,000 2,426,000 -110,000 -6,319,000 16,428,000 -1,751,000 10,297,000 -6,127,000 -4,634,000 1,186,000 28,478,000 -13,748,000 -8,263,000 -18,162,000 72,650,000 -10,847,000 -5,493,000 -48,989,000 150,877,000 1,182,000 789,000 46,000 421,000 36,000 20,000 -1,033,000 1,829,000 -3,497,000 -336,000 120,000 820,000 592,000 205,000 -459,000 695,000 32,000 117,000 44,000 4,000 43,000 386,000 -9,000 1,429,000 20,000 349,000 1,774,000 894,000 239,000 501,000 -26,000 6,222,000 
          foreign currency effect
        281,000 -112,000 -7,527,000 12,147,000 -21,514,000 8,139,000 -2,695,000 -3,879,000 8,574,000 -4,183,000 -844,000 3,144,000 6,451,000 659,000 -6,502,000 -2,298,000 -1,023,000 -1,461,000 978,000 -1,338,000 778,000 4,562,000 2,528,000 -426,000 1,429,000 -4,444,000 502,000 -209,000  -249,000 -6,517,000 5,513,000  7,995,000 14,031,000 2,080,000  1,064,000 -4,789,000 3,791,000  -1,078,000 1,275,000 -4,569,000  -4,049,000 -437,000 2,978,000    -2,275,000  1,122,000 -2,919,000 1,198,000  -4,901,000 -349,000 1,114,000  41,000 30,000 -3,000  32,000 12,000 -40,000  3,000 -4,000 11,000  8,000 -17,000 6,000 2,000 1,000 4,000 -19,000             
          net cash increase in cash and cash equivalents
                                                                                                    
          cash and cash equivalents at beginning of period
        134,134,000 149,673,000 153,891,000 190,606,000    268,345,000         103,172,000 177,187,000 144,479,000 85,700,000 54,885,000 58,152,000 23,839,000 26,584,000 21,677,000 25,303,000 1,170,000 2,440,000 1,364,000 -6,525,000 7,603,000 274,000 496,000 456,000 
          cash and cash equivalents at end of period
        6,583,000 25,953,000 -34,845,000 163,142,000 -16,447,000 27,115,000 -1,641,000 125,107,000 -4,681,000 -14,317,000 2,041,000 166,630,000 14,728,000 -18,095,000 -20,659,000 177,917,000    170,955,000         -7,532,000 -18,205,000 -5,125,000 70,482,000 -44,454,000 -16,551,000 30,270,000 133,907,000 44,374,000 806,000 -78,549,000 210,556,000 15,307,000 27,529,000 22,062,000 79,581,000 20,531,000 22,015,000 -14,497,000 57,651,000 18,882,000 -13,398,000 1,424,000 47,977,000 -14,127,000 -5,015,000 -23,307,000 100,601,000 6,777,000 -10,573,000 21,051,000 6,584,000 1,349,000 4,786,000 1,936,000 18,513,000 -3,227,000 -1,263,000 982,000 25,185,000 10,094,000 1,600,000 11,046,000 2,563,000 -625,000 -442,000 -674,000 2,911,000 1,221,000 -857,000 120,000 1,956,000 -15,000 -168,000 -6,853,000 8,400,000 800,000 -410,000 118,000 336,000 -328,000 -738,000 -2,869,000 4,209,000 
          supplemental disclosure of cash flow information:
                                                                                                    
          cash paid for interest
        2,776,000 3,078,000 3,629,000 3,128,000 2,985,000 3,299,000 3,413,000 3,310,000 3,505,000 3,097,000 3,405,000 3,235,000 3,004,000 2,425,000 488,000 421,000 555,000 368,000 611,000 844,000 1,198,000 1,039,000 1,430,000 537,000 1,025,000 725,000 1,460,000 1,252,000 1,410,000 1,009,000 1,627,000 981,000 1,369,000 981,000 1,332,000 858,000 1,066,000 437,000 1,068,000 458,000 1,406,000 530,000 375,000 515,000 568,000 682,000 583,000 725,000 404,000 881,000 894,000 474,000 758,000 641,000 1,272,000 874,000 1,641,000 877,000                                   
          non-cash investing activities:
                                                                                                    
          period-end balance of accounts payable for property and equipment
        3,094,000 -3,686,000 2,774,000 3,871,000 -2,492,000 1,216,000 -2,213,000 8,643,000 3,253,000 416,000 1,715,000 2,370,000                                                                                 
          deferred purchase price of receivables factored in the period
            1,108,000 3,721,000 4,447,000 2,541,000 4,822,000 1,783,000 4,739,000                                                                                 
          taxes withheld and paid on employees' stock based compensation
         -68,000 -14,000 -1,224,000                                                                                         
          net increase in cash and cash equivalents
           29,008,000  27,115,000 -1,641,000 -24,566,000   2,041,000 12,739,000        -97,390,000                -43,280,000 44,374,000 806,000 -78,549,000 66,077,000 15,307,000 27,529,000 22,062,000 -6,119,000 20,531,000   2,766,000 18,882,000 -13,398,000 1,424,000 -10,175,000 -14,127,000 -5,015,000 -23,307,000 76,762,000 6,777,000    1,349,000 4,786,000   -3,227,000 -1,263,000 982,000 -118,000 10,094,000 1,600,000 11,046,000 1,393,000   -674,000 471,000 1,221,000 -857,000 120,000 592,000 -15,000 -168,000 -328,000 797,000 800,000 -410,000 118,000 62,000 -824,000 -738,000 -2,869,000 3,753,000 
          cash paid for taxes
         9,328,000 7,691,000 5,152,000 1,367,000 7,170,000 7,400,000 4,900,000 4,380,000 7,274,000 6,083,000 5,536,000 8,136,000 4,867,000 5,375,000 3,267,000    2,555,000    3,525,000 4,332,000 3,154,000 56,000 3,466,000 3,904,000 1,155,000 11,230,000 6,870,000 9,581,000 8,329,000 7,213,000 51,618,000 3,425,000 4,783,000 4,058,000 9,342,000 8,506,000 4,486,000 4,616,000 14,768,000 8,575,000 3,292,000 5,200,000 4,689,000 4,152,000 3,814,000 1,841,000 1,519,000 2,767,000 1,346,000 3,796,000 536,000 2,260,000 1,954,000   -124,000 1,000   -53,000 76,000 298,000 -3,000 19,000 61,000 111,000 69,000 52,000                   
          net decrease in cash and cash equivalents
                     -18,095,000 -20,659,000 -12,689,000              -18,205,000 -5,125,000 -32,690,000  -16,551,000                         21,051,000 -20,000,000    -3,164,000                             
          other
           1,082,000 -99,000 -194,000 -21,000 -842,000 2,839,000 340,000 -215,000 -44,000 -160,000 173,000 452,000 256,000    -200,000     1,423,000                                                                    
          acquisition of businesses, net of cash acquired
                    18,610,000                                                                                
          taxes withheld and paid on employees' stock-based compensation
                                                                                                    
          acquisition contingent consideration payment
                        -1,000 -68,000                                                                        
          gain on sale of patents
                                                                                                  
          proceeds from the sale of patents and property and equipment
                        11,000 1,000   1,072,000 7,000                                                                       
          acquisition of intangible assets
                            -3,141,000                                                                     
          net cash from provided by financing activities
                                                                                                    
          non-cash stock based compensation
                     -1,880,000 2,984,000 2,279,000 5,108,000 3,223,000 3,459,000 2,740,000 2,260,000                                                                        
          impairment loss
                                 837,000 9,885,000 10,484,000                                                                
          net loss on divestitures
                                                                                                    
          acquisition of business
                                                                                                   
          proceeds from divestiture of businesses
                                                                                                    
          borrowing of debt
                            1,000 31,647,000 169,546,000 8,342,000 1,099,000 17,943,000 10,428,000 76,679,000 3,000,000       40,000,000 75,000,000    78,137,000 13,455,000 -3,254,000 2,643,000 5,839,000 40,441,000 40,000 3,205,000 40,000 41,000 1,085,000 69,083,000 68,000,000                                 
          cash paid for the cancellation of restricted stock
                        -117,000 -1,874,000 -585,000 -1,532,000 -306,000 -340,000 -67,000 -404,000 -189,000 -287,000 -550,000 -376,000 -306,000 -223,000 -659,000 -737,000 -174,000 -926,000 -403,000 -793,000 -1,008,000 -467,000                                                 
          cash paid for financing costs
                                          1,000 -650,000                 -336,000 -126,000 -141,000 -3,890,000                                 
          net increase in cash, cash equivalents and restricted cash
                        -4,480,000 8,223,000   39,306,000 17,364,000 -13,769,000 172,496,000 5,244,000   1,649,000                                                                 
          cash, cash equivalents and restricted cash at beginning of period
                          52,948,000 39,620,000                                                                 
          cash, cash equivalents and restricted cash at end of period
                        -4,480,000 8,223,000   39,306,000 17,364,000 -13,769,000 225,444,000 5,244,000 11,523,000 -5,088,000 41,269,000                                                                 
          change in defined benefit pension plans
                         19,000 -192,000 -477,000                                                                         
          cash paid (refund) for taxes
                         3,785,000                                                                           
          operating lease expense
                          2,054,000 2,575,000 2,001,000 1,666,000 1,839,000 1,651,000 1,696,000 1,574,000 1,570,000 1,333,000                                                                 
          cost of technology investment
                                                                                                    
          loss on sale of property and equipment
                           242,000 121,000 223,000 220,000 119,000 143,000 92,000 49,000 178,000 329,000 117,000 2,071,000 85,000 174,000 619,000 146,000 103,000 177,000 37,000 225,000 29,000 61,000                                                   
          acquisition of subsidiary, net of cash acquired
                                 653,000           73,000                                                       
          defined benefit pension plan income
                                                                                                    
          gain on sale of business
                                 -4,970,000                                                                 
          proceeds from divestiture of business
                                                                                                    
          cash (refund) paid for taxes
                             2,865,000                                                                       
          defined benefit plan income
                                 -55,000 -82,000 -617,000        -16,000        -9,000    1,000                                             
          allowance for credit losses
                              154,000 451,000                                                                     
          defined benefit plan expense
                               85,000       -401,000 298,000  2,000    34,000 72,000 45,000  179,000        -54,000 -52,000 -53,000 353,000 -96,000 -102,000 -105,000 263,000 -66,000 -6,000 75,000 63,000 64,000 61,000 63,000 69,000 47,000 48,000 47,000                         
          provision of doubtful accounts
                                144,000 -336,000 316,000 229,000  43,000 163,000 41,000  -359,000 60,000 -54,000  111,000 -300,000 574,000  57,000 127,000 125,000  830,000 -326,000 -4,000  377,000 -442,000 434,000  -95,000                                       
          asset impairments and net loss on divestitures
                                                                                                    
          other current assets
                                                                                                    
          other current liabilities
                                                                                                    
          acquisition of business, net of cash acquired
                                                                                                    
          proceeds from divestitures of businesses
                                                                                                    
          stock compensation
                                 1,977,000 1,323,000 1,968,000 2,687,000 2,297,000 1,861,000 2,202,000 3,948,000 3,798,000 2,458,000 2,303,000 2,330,000 2,351,000 2,687,000 1,818,000 1,331,000 1,704,000 1,625,000 1,358,000 1,203,000 1,224,000 1,355,000 870,000 775,000 863,000 507,000 491,000 341,000 394,000 225,000 292,000 508,000                                    
          prepaid expenses and other assets
                                 9,318,000 5,829,000 -5,553,000 3,439,000 4,227,000 -7,213,000 -4,881,000 -11,779,000 4,592,000 1,345,000 -6,492,000 6,280,000 9,716,000 -5,262,000 -1,628,000 -9,809,000 5,361,000 -2,769,000 -3,905,000 2,369,000 -1,281,000 -1,173,000 -5,786,000 -6,988,000 1,633,000 -2,580,000 -1,511,000 4,036,000 -373,000 -5,232,000 -1,659,000 2,061,000 -492,000 550,000 -182,000 81,000 -388,000 -494,000 546,000 -178,000 -120,000 -417,000 323,000 199,000 -36,000 157,000 -141,000 553,000 103,000 -934,000 -34,000 -176,000 386,000 -439,000 -47,000 319,000 86,000 -124,000 15,000 189,000 -19,000 5,000 165,000 -150,000 -166,000 -92,000 228,000 
          accrued liabilities
                                 3,915,000 698,000 -6,785,000 -6,583,000 9,322,000 774,000 -10,808,000 9,725,000 -1,952,000 293,000 -38,237,000 -2,809,000 -6,906,000 5,210,000 7,819,000 4,975,000 2,291,000 8,391,000 -6,970,000 -371,000 3,183,000 592,000 904,000 7,789,000 1,727,000 -118,000 2,490,000 -6,401,000 3,528,000 3,450,000 3,737,000 5,373,000 -2,384,000 378,000 -101,000 1,647,000 15,000 383,000 49,000 791,000 192,000 504,000 -467,000 -597,000 555,000 364,000 -777,000 624,000 202,000 917,000 -125,000 313,000 555,000 131,000 -469,000 36,000 348,000 302,000 -63,000 -150,000 310,000 -286,000 104,000 -58,000 247,000 -158,000 -63,000 
          proceeds from sale of a business
                                 47,500,000                                                                 
          repurchase of common stock
                                 -25,000,000 -25,000,000 -8,040,000  -43,910,000                                                               
          supplemental disclosure of non-cash transactions:
                                                                                                    
          common stock issued to board of directors and employees
                                 1,557,000 1,438,000 1,581,000  1,474,000 1,057,000 1,362,000  1,644,000 1,104,000 1,125,000  1,075,000 1,448,000 984,000  898,000 716,000 673,000  696,000 835,000 495,000  654,000 105,000 269,000  165,000 2,000 147,000                                     
          net decrease in cash, cash equivalents and restricted cash
                                                                                                    
          final payment for acquisition of subsidiary, net of cash acquired
                                     -15,000                                                             
          adjustments to reconcile net income to cash from operating activities:
                                                                                                    
          benefit from doubtful accounts
                                                                                                    
          changes in operating assets and liabilities:
                                                                                                    
          investment in subsidiary, net of cash acquired
                                                   -47,000    -628,000                                             
          investment in development-stage entity
                                                                                                    
          excess tax benefit from equity awards
                                            7,786,000 108,000 -385,000 5,461,000 -242,000   -2,173,000 -151,000 6,328,000 -2,173,000 -757,000 -1,113,000   1,406,000 -509,000 -609,000 -459,000 -213,000 -827,000                                   
          foreign currency effect on cash and cash equivalents
                                                                                                    
          common stock issued to directors and employees
                                                                                                    
          gain on crs settlement
                                                                                                    
          revaluation of derivatives
                                                                                                    
          income from write-off of intangible assets
                                                                                                    
          settlement of derivative financial instruments
                                                                                                    
          excess tax expense from equity awards
                                                                                                    
          gain on revaluation of financial derivatives
                                               -456,000  -801,000 174,000 -324,000  -1,047,000 340,000 -557,000  -981,000 -634,000 -1,244,000  -25,000 1,432,000 -2,471,000                                     
          final payment for acquisition of csz, net of cash acquired
                                           -2,000,000                                                         
          debt extinguishment expenses
                                                                                                    
          loss from write-off of intangible assets
                                                                                                    
          provision for doubtful accounts
                                                                                                    
          defined benefit pension plan expense
                                                                                                    
          gain from equity investment
                                                                                                    
          deferred income tax benefit
                                             1,774,000 1,466,000 -5,173,000  503,000 -2,282,000 -2,483,000                                                 
          loss on write-off or intangible assets
                                                                                                    
          purchase of non-controlling interest
                                                        -1,732,000 -8,000 -6,525,000 -40,302,000                                         
          cash invested in corporate owned life insurance
                                                                     -57,000                            
          distribution paid to non-controlling interest
                                                            -117,000 -173,000                                     
          redemption of series c preferred stock
                                                                                                    
          series c preferred stock holders dividend
                                                                -1,241,000                                    
          issuance of common stock to non-controlling interest
                                                        -17,000 42,534,000                                         
          issuance of common stock for series c preferred stock conversion
                                                        -400,000 7,232,000 6,621,000 1,655,000                                         
          capital lease
                                                                                                    
          loss on write-off of intangible assets
                                                                                                    
          acquisition and investment in subsidiary, net of cash acquired
                                                                                                  
          (gain) loss on sale of property and equipment
                                                   -8,000                                                 
          (gain) loss on revaluation of derivatives
                                                                                                    
          loss on sale of property, plant & equipment
                                                                                                    
          (gain) income from equity investment
                                                                                                    
          purchases of derivative financial instruments
                                                                                                  
          loan to equity investment
                                                            -240,000 -350,000                                     
          proceeds from public offering of common stock
                                                            45,000 -60,000 75,547,000                                     
          proceeds from sale of w.e.t. equity to non-controlling interest
                                                                                                 
          deferred tax provision
                                                     15,000 -4,505,000 -1,804,000  72,000 -470,000 -740,000  1,309,000 161,000 920,000  -2,138,000 690,000 1,596,000  1,416,000 1,201,000 823,000  190,000 -305,000 -472,000  382,000 683,000 748,000  -1,122,000 788,000 817,000  521,000 471,000 446,000             
          gain on equity investment
                                                                                                    
          unrealized foreign currency gain
                                                                                                    
          gain realized from step acquisition of subsidiary
                                                     -785,000                                             
          purchase of property and equipment
                                                     -11,501,000 -8,720,000 -6,769,000  -11,984,000 -11,916,000 -6,116,000 -11,449,000 -7,218,000 -5,097,000 -3,029,000 -6,812,000 -577,000 -2,551,000 -696,000 -404,000 -55,000 -126,000 -372,000 -324,000 -51,000 -171,000 -198,000 -107,000 -358,000 -373,000 -874,000 -681,000 -1,135,000 -841,000 -94,000 -389,000 -372,000 -356,000 -401,000 -234,000 -34,000 -99,000 -60,000  -34,000 -181,000 -225,000 -23,000 -290,000 -189,000 -169,000 
          distribution paid to non-controlling interests
                                                                                                    
          cash paid to series c preferred stock holders
                                                         -197,000 -677,000 -8,268,000  -8,564,000 -8,721,000 -55,000                                     
          loss on sale of property, plant and equipment
                                                      4,000 24,000  64,000 -19,000 3,000  -3,000                                       
          proceeds from the sale of property, plant and equipment
                                                      44,000  -2,000 8,000 1,000  2,000 4,000 14,000                                     
          deferred income tax expense
                                                                                                    
          sales and maturities of short-term investments
                                                                                                    
          equity investment
                                                                        -7,000                            
          patent costs
                                                             -1,919,000 -338,000 -336,000 -259,000 -204,000 -299,000 -418,000 -244,000 -202,000 -253,000 -162,000 -144,000 -227,000 -268,000 -191,000 -149,000 -244,000 -108,000 -153,000 -123,000 -138,000 -1,586,000 -89,000 -53,000 -147,000 -51,000 -57,000 -52,000 5,000 -113,000 -46,000         
          proceeds from the sale of series c convertible preferred stock
                                                                -538,000 -2,573,000 64,514,000                                 
          proceeds from the sale of embedded derivatives
                                                                                                  
          loss on equity investment
                                                         -121,000 -21,000 -176,000  -3,000 33,000 198,000                                     
          purchase of derivative financial instruments
                                                                                                    
          distributions paid to non-controlling interests
                                                                                                    
          loss on revaluation of derivatives
                                                                                                    
          purchases of short-term investments
                                                                    -2,717,000 -1,768,000 -1,887,000 -5,240,000         -9,725,000 -9,300,000 -10,512,000 -9,325,000 -8,501,000 -5,400,000 -2,500,000 -3,500,000 -4,250,000 -4,050,000           
          proceeds from sale of common stock, net of cash expenses
                                                                                                    
          issuance of common stock for series c preferred stock redemption
                                                            7,780,000                                    
          issuance of common stock for series c preferred stock dividend
                                                            1,000 1,030,000                                    
          debt retirement expense
                                                                 3,000                                   
          maturities of short-term investments
                                                                   9,761,000  1,146,000 2,894,000 1,348,000                             
          purchase of w.e.t. automotive ag, net of cash acquired
                                                                                                   
          fund restricted cash
                                                                                                    
          acquisition transaction expenses
                                                                   3,754,000                                 
          gain on sale of property, plant and equipment
                                                               -8,000                                     
          acquisition transaction costs
                                                                   -699,000                                 
          cash restricted for acquisition
                                                                   -182,002,000                                 
          revolving note borrowings
                                                                   19,011,000                                 
          income from equity investment
                                                                                                    
          common stock issued to employees and consultants
                                                                                                    
          loss on revaluation of financial derivatives
                                                                 4,305,000                                   
          sales of short-term investments
                                                                                4,450,000 6,812,000 9,875,000 5,876,000 5,475,000 4,775,000 3,150,000 4,400,000 2,600,000 4,150,000           
          purchase of zt plus assets, net of cash acquired
                                                                    -1,500,000                             
          issuance of common stock under the 2006 equity incentive plan
                                                                 60,000    -64,000 81,000  25,000 26,000 273,000  46,000 46,000 298,000  389,000                 
          stock option compensation
                                                                  274,000 357,000 304,000 330,000 328,000 313,000 333,000 330,000 333,000 274,000 347,000 327,000 218,000 217,000 171,000 171,000 182,000 218,000 505,000 105,000 114,000 98,000             
          loss from equity investment
                                                                    22,000 369,000                            
          proceeds from the sale of derivative financial instruments
                                                                   2,610,000                                 
          loss on disposal of property and equipment
                                                                              3,000    -4,000                
          cash used to repurchase common stock
                                                                                                    
          contribution to equity investment
                                                                                                   
          revolving credit line borrowings
                                                                           1,300,000                         
          purchases of investments
                                                                             -3,100,000                     
          sales and maturities of investments
                                                                             1,525,000 10,150,000 3,850,000                     
          common stock issued to employees
                                                                                                    
          purchase of long-term investments
                                                                                                    
          proceeds from property and equipment sales
                                                                                                    
          checks issued in excess of bank balance
                                                                                   605,000                 
          other non cash income
                                                                                                    
          proceeds from the exercise of warrants and options
                                                                                     117,000 44,000 4,000             
          warrants granted pursuant to value participation agreement
                                                                                                    
          gain from sale of assets
                                                                                                  
          options granted to bsst minority shareholder
                                                                                                    
          compensation from grant of non-employee stock options and warrants
                                                                                                    
          proceeds from sale of property and equipment
                                                                                                   
          other investing activities
                                                                                            -2,000 -24,000 -5,000 -28,000 -11,000 
          repayment of proceeds from bank financing
                                                                                                    
          compensation from grant of non-employee stock options
                                                                                                    
          proceeds from the exercise of warrants and options, net of cash expenses
                                                                                         386,000 -9,000 1,429,000         
          amortization of debt discount
                                                                                                    
          (repayment of) proceeds from bank financing
                                                                                                    
          net repayment of bridge financing
                                                                                                    
          net loss
                                                                                            265,000 -146,000 -609,000 -925,000 -1,141,000 -1,411,000 -1,655,000 -2,099,000 
          adjustments to reconcile net loss to cash from operating activities:
                                                                                                    
          depreciation and amortization warrants granted pursuant to value participation agreement
                                                                                                    
          deferred revenue
                                                                                                    
          purchase of property and equipment patent costs proceeds from sale of property and equipment
                                                                                                    
          proceeds from deferred manufacturing agreement
                                                                                                    
          repayment of capital lease
                                                                                                    
          net (repayment) proceeds from bridge financing
                                                                                                    
          grant of warrants
                                                                                             160,000       
          change in operating assets and liabilities:
                                                                                                    
          decrease in restricted cash
                                                                                                    
          repayment of bank financing
                                                                                             136,000       
          proceeds from issuance of common stock
                                                                                             226,000    6,500,000 
          cost of issuance of common stock
                                                                                             -13,000    -26,000 -778,000 
          proceeds from bridge financing
                                                                                                 501,000 500,000 
          increase in restricted cash
                                                                                                  183,000 -7,000 
          proceeds from bank financing
                                                                                               894,000     
          amortization of debt discount including beneficial conversion feature
                                                                                                    
          extraordinary gain on extinguishment of debt
                                                                                                    
          net proceeds from sale of common stock
                                                                                                    
          net proceeds (repayment) from bridge financing